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Abstract	  
Acid-sensing ion channels (ASICs) and the Epithelial Na+ channel (ENaC) are both members 
of the ENaC/DEG (degenerin) family of amiloride-sensitive Na+ channels. ASICs act as 
proton sensors in the nervous system where they contribute, besides other roles, to fear 
behavior, learning and pain sensation. ENaC mediates Na+ reabsorption across epithelia of the 
distal kidney and colon and of the airways.  ENaC is a clinically used drug target in the 
context of hypertension and cystic fibrosis, while ASIC is an interesting potential target. 
Following a brief introduction we will review here selected aspects of ASIC and ENaC 
function. We discuss the origin and nature of pH changes in the brain and the involvement of 
ASICs in synaptic signaling. We expose how in the peripheral nervous system, ASICs cover 
together with other ion channels a wide pH range as proton sensors. We introduce the 
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mechanisms of aldosterone-dependent ENaC regulation and the evidence for an aldosterone-
independent control of ENaC activity, such as regulation by dietary K+.  We then provide an 
overview of the regulation of ENaC by proteases, a topic with increasing interest over the last 
years. In spite of the profound differences in the physiological and pathological roles of 
ASICs and ENaC, these channels share many basic functional and structural properties. It is 
likely that further research will identify physiological contexts in which ASICs and ENaC 
have similar or overlapping roles.  
	  
Abbreviations	  
AQP, aquaporin; ASDN, aldosterone-sensitive distal nephron; ASIC, acid-sensing ion 
channel; BASIC, bile acid-activated ion channel; BK, big calcium-activated K+ channel; CA, 
carbonic anhydrase; CAP-1, -2, or-3, channel activating proteases; Cav, voltage-gated Ca2+ 
channel; CCD, cortical collecting duct; CD, collecting duct; PHA-1, 
pseudohypoaldosteronism type 1; CFTR, cystic fibrosis transmembrane conductance 
regulator; CNT, connecting tubule; CF, cystic fibrosis; CLCN/Kb, voltage-sensitive chloride 
channel Kb; DCT, distal convoluted tubule; DRG, dorsal root ganglion; ENaC, amiloride-
sensitive epithelial sodium channel; EPSP, excitatory post-synaptic potential; FaNaC, 
FMRFa-activated Na+ channel; FMRFa, Phe-Met-Arg-Phe-amide; GMQ, 2-guanidine-4-
methylquinazoline; GPI, glycosylphosphatidyl-inositol; HAI, hepatocyte growth factor 
activator inhibitor; HCN, hyperpolarization-activated cyclic nucleotide-gated channel; IA, A-
type current of rapid inactivating K+ channels; iGluR, ionotropic glutamate receptor; IK, K+ 
current; INa, Na+ current; Ih, current produced by HCN channels; Imax, maximal current 
amplitude; Kir, inward rectifier K+ channel; Kv, voltage-gated K+ channel; MR, 
mineralocorticoid receptor; Nav, voltage-gated Na+ channel; NBC, Na+,-HCO3- cotransporter; 
NCC, Na+-Cl− cotransporter; NHE, Na+-H+ exchanger; OSR1/SPAK, Ste20-related protein 
kinases; P2X, purinergic receptor; PcTx1, Psalmotoxin 1; pH50, pH of half-maximal effect; 
pHe, extracellular pH; pH50Inh./Act., pH of half-maximal inhibition/activation; PMCA, 
plasma membrane Ca2+-ATPase; PNS, peripheral nervous system; PPK, pickpocket; ROMK, 
renal outer medullary potassium channel; SPLUNC1, the short palate, lung, and nasal epithelial 
clone 1; TASK, two-pore domain K+ channel; TRAAK, TWIK-related arachidonic acid-
stimulated K+ channel; TREK, TWIK-related K+ channel; TRPM, transient receptor potential 
cation channel, subfamily M; TRPV, transient receptor potential cation channel subfamily V; 
TWIK, tandem of P-domain in a weak inwardly rectifying K+ channel; V-ATPase, vacuolar-
type H+-ATPase. 
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Introduction	  	  
The ENaC/DEG superfamily of ion channels includes besides ENaC and ASICs the DEGs 
that are part of mechanotransduction complexes in C. elegans (Arnadottir, O'Hagan, Chen, 
Goodman & Chalfie, 2011), the peptide-gated channel FaNaC of snails (Lingueglia, Deval & 
Lazdunski, 2006), the mammalian “bile acid-sensitive ion channel” BASIC, (Wiemuth, 
Assmann & Grunder, 2014)  as well as Drosophila ENaC/DEG channels such as pickpocket 
(PPK), ripped pocket and others (Adams, Anderson, Motto, Price, Johnson & Welsh, 1998) 
(Fig. 1A). The amino acid sequence identity between different ENaC/DEG subfamilies is 15-
20%.  
ASICs and FaNaC are expressed in the nervous system, DEGs are present in touch-sensitive 
neurons, BASIC shows highest expression in the brain, the liver and the intestine, and ENaC 
is found at highest levels in tight epithelia, while the Drosophila ENaC/DEG members are 
probably expressed in many different tissues. FaNaC is an excitatory ion channel of the 
nervous system of snails, DEGs are critical for C. elegans touch sensation, and Drosophila 
ENaC/DEG members may also be involved in touch sensation, among other roles. BASIC is 
activated by bile acids, its physiological role is however currently not known. ASICs are 
involved in fear behaviors, learning and memory functions, as well as pain sensation (Fig. 
1B).  They also contribute to neurodegeneration after ischemic stroke (rev. in (Kellenberger & 
Schild, 2015; Wemmie, Taugher & Kreple, 2013)). ENaC plays a well-established role in Na+ 
reabsorption in the distal nephron and the distal colon and on airway epithelia, is involved in 
salt taste perception, epidermal differentiation and in skin barrier function (Fig. 1B).  
Crystal structures of chicken ASIC1, which was in some studies co-crystallized with the 
ASIC toxins Psalmotoxin 1 (PcTx1) or Mit-Toxin, showed a channel made by three subunits  
(Baconguis, Bohlen, Goehring, Julius & Gouaux, 2014; Baconguis & Gouaux, 2012; Dawson 
et al., 2012; Gonzales, Kawate & Gouaux, 2009; Jasti, Furukawa, Gonzales & Gouaux, 2007). 
The shape of each subunit was compared to that of a hand holding a small ball, and 
accordingly the different extracellular domains were labeled palm, knuckle, finger, thumb and 
β-ball (Fig. 2A). The palm domain is the extracellular continuation of the transmembrane 
segments and forms a β-strand-rich scaffold of the extracellular channel part. The knuckle and 
β-ball are located on top and along the upper half of the palm, respectively (Fig. 2A-B). The 
finger and thumb are oriented towards the outside of the protein. Details of the crystal 
structures and their differences have been recently discussed (Grunder & Augustinowski, 
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2012; Kellenberger & Grutter, 2015; Kellenberger & Schild, 2015). Structure-function studies 
indicate that the ENaC and ASIC ectodomains play important roles in controlling the opening 
of the channel pore (rev. in (Kellenberger & Schild, 2015)). The sequence homology suggests 
that all ENaC/DEG members share the same subunit topology. Models of ENaC subunits 
have been constructed based on the ASIC crystal structures. The highest homology of the 
ectodomain between ASICs and ENaC is found in the palm and the β-ball (Kashlan et al., 
2011; Kashlan & Kleyman, 2011). The predicted secondary structures of most other ENaC 
domains match the ASIC structure moderately well except for the finger that has the lowest 
homology, and contains a ~80 amino acid insertion in ENaC (Fig. 2C).  
Stoichiometry predictions of ENaC that were based on functional and biochemical data 
strongly suggested that the functional ENaC at the plasma membrane is a tetramer 
(Anantharam & Palmer, 2007; Firsov, Gautschi, Merillat, Rossier & Schild, 1998; Kosari, 
Sheng, Li, Mak, Foskett & Kleyman, 1998). In contrast, all crystal structures describe ASIC 
as a trimer. In a recent study ASIC1a and ASIC2a containing fluorescently labeled subunits 
were expressed in Xenopus oocytes and the number of bleaching steps of plasma membrane-
resident channels was counted to determine the subunit stoichiometry of these functional 
channels at the cell surface. This study concluded that the ASICs are trimers (Bartoi, 
Augustinowski, Polleichtner, Grunder & Ulbrich, 2014). A recent biochemical study shows 
however evidence for the existence of ASIC1a tetramers (van Bemmelen, Huser, Gautschi & 
Schild, 2015). The question of the ENaC/DEG subunit stoichiometry remains currently 
controversial.  
  
ASICs	  
Basic	  information	  on	  ASICs	  
Physiological	  and	  pathological	  roles	  of	  ASICs	  
Of the ASIC subunits that participate in the formation of H+-activated channels, ASIC1a, -2a 
and -2b are widely expressed in the CNS; all ASIC subunits are found in the peripheral 
nervous system (PNS) (rev. in (Kellenberger & Schild, 2015; Wemmie, Taugher & Kreple, 
2013). Since ASICs are Na+-selective ion channels, their activation is expected to induce a 
neuronal depolarization. Indeed, activation of ASICs in neurons of the CNS and PNS induces 
membrane depolarization and action potential induction (Fig. 3A) (Deval, Baron, Lingueglia, 
Mazarguil, Zajac & Lazdunski, 2003; Poirot, Berta, Decosterd & Kellenberger, 2006; 
Vukicevic & Kellenberger, 2004). ASIC1a shows in addition to its Na+ permeability a small 
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permeability for Ca2+ that is likely important for some of its roles (Bassler, Ngo-Anh, Geisler, 
Ruppersberg & Grunder, 2001; Boillat, Alijevic & Kellenberger, 2014; Waldmann, 
Champigny, Bassilana, Heurteaux & Lazdunski, 1997). 
Synaptic signaling involves an acidification of the synaptic cleft, which can activate ASICs. 
Disruption of the ASIC1a-encoding gene in mice eliminated most of the ASIC currents of 
CNS neurons, impaired long-term potentiation in the hippocampus and induced a mild deficit 
in spatial learning (Wemmie et al., 2002). Recent studies have added important information 
on the role of ASICs in synaptic functions. ASIC1a is highly expressed in the amygdala, and 
there is strong evidence that ASIC1a of the amygdala contributes to fear behavior (Wemmie, 
Taugher & Kreple, 2013). Disruption of ASIC1a or inhibition of ASIC1a activity in the brain 
by PcTx1-containing venom reduced the infarct volume in an experimental stroke model by 
>50%, strongly suggesting that ASIC1a-mediated Ca2+ entry contributes to neurodegeneration 
in this situation (Xiong et al., 2004). Further studies showed that disruption of ASIC1a had a 
protective effect in several neurodegenerative diseases, including multiple sclerosis, and 
Huntington’s and Parkinson’s disease (rev. in (Wemmie, Taugher & Kreple, 2013)). The 
extracellular pH is lowered in inflammation and ischemia, which both involve pain. There is 
also strong evidence for a role of sensory neuron ASICs in pain sensation. ASICs belong to 
the same ion channel family as the C. elegans degenerins that form the channel parts of 
mechanotransduction complexes. A large number of studies with ASICs provide evidence for 
a regulatory role of ASICs in mechanosensation in several tissues and organs (rev. in 
(Omerbasic, Schuhmacher, Bernal Sierra, Smith & Lewin, 2015)). 
	  
ASIC	  function	  and	  regulation	  
Exposure of ASICs to an acidic extracellular pH leads to rapid channel opening, followed by 
a slower entry into a non-conducting desensitized state. This results in a transient current (Fig. 
3B). In some ASIC subtypes, such as ASIC3 and some heteromeric ASICs, desensitization is 
not complete and a small sustained current persists after the initial peak (Lingueglia et al., 
1997; Waldmann, Champigny, Bassilana, Heurteaux & Lazdunski, 1997; Yagi, Wenk, Naves 
& McCleskey, 2006). Desensitization can also occur without apparent channel opening 
(termed steady-state desensitization in this case) during moderate lowering of the pH, and can 
limit the availability of ASICs for opening. The pH dependence of these two processes, 
channel activation and steady-state desensitization, is illustrated at the example of ASIC1a in 
Fig. 3C. The steady-state desensitization occurs at pH < 7.4, with a mid-point, termed pH of 
half-maximal desensitization of ~ 7.15. ASIC1a opening occurs at pH < 7 and is characterized 
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by a pH of half-maximal activation (pH50) of ~6.5. These parameters determine the open 
probability of ASICs under given pH conditions. As shown in Table 2, ASIC1a and ASIC3 
are the most sensitive ASICs and are activated by acidification to pH values only slightly 
below pH 7. In contrast, ASIC2a needs much more acidic pH (<5.5) for activation. ASIC1a is 
the ASIC isoform that is most sensitive to desensitization. It shows partial desensitization 
already at pH slightly below 7.4 (Fig. 3C and Table 2).  
For several ASICs it has been shown with fast solution changes that the opening time constant 
at a pH that fully activates the channels is of the order of ~10 ms (Bassler, Ngo-Anh, Geisler, 
Ruppersberg & Grunder, 2001). The kinetics of current desensitization depend on the subunit 
composition, as shown in Table 2. Besides protons there are only very few ASIC activators 
known so far. The small	   synthetic	   molecule	   2-­‐guanidine-­‐4-­‐methylquinazoline (GMQ) 
activates ASIC3 at pH 7.4 and inhibits other ASIC subtypes by changing the pH dependence 
of activation and of steady-state desensitization (Alijevic & Kellenberger, 2012; Yu et al., 
2010). Interestingly, endogenous arginine metabolites that contain a guanidinium group as 
does GMQ were found to have similar effects as GMQ (Li, Yu, Zhang, Cao & Xu, 2011).  
ASIC activity is regulated by many different modulators, such as divalent and polyvalent 
cations, neuropeptides, arachidonic acid, protein kinases and proteases, as summarized in 
Table 3. Many of these regulatory mechanisms are likely active under physiological 
conditions. Divalent and polyvalent cations such as Ca2+, Mg2+ and spermine appear to 
compete with protons for binding sites, since an increase in their concentration shifts the 
ASIC pH dependence towards more acidic pH values. The peptide Phe-Met-Arg-Phe-amide 
(FMRFa) activates the ENaC/degenerin family member FaNaC (Lingueglia, Champigny, 
Lazdunski & Barbry, 1995). FMRFa and related mammalian neuropeptides slow the 
desensitization kinetics of ASIC1 and ASIC3 and induce a sustained current, with EC50 
values that are for most peptides on the order of 10-50 µM (Askwith, Cheng, Ikuma, Benson, 
Price & Welsh, 2000; Vick & Askwith, 2015). Arachidonic acid, whose tissue concentration 
is increased in ischemia and inflammation, potentiates ASIC currents in the CNS and the PNS 
by mechanisms that include an alkaline shift of the pH dependence of activation (Allen & 
Attwell, 2002; Deval et al., 2008; Smith, Cadiou & McNaughton, 2007). Trypsin was shown 
to shift the ASIC1a pH dependence of activation and steady-state desensitization to more 
acidic values by a cleavage in the ectodomain. This led to reduced acidification-induced ASIC 
currents and neuronal signaling at a physiological conditioning pH 7.4, and to an increased 
activity if the conditioning pH was slightly reduced (Vukicevic & Kellenberger, 2004; 
Vukicevic, Weder, Boillat, Boesch & Kellenberger, 2006). The serine protease tissue 
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kallikrein was also shown to cleave and regulate ASIC1a (Su, Tang, Liu, Zhou & Dong, 
2011). Finally, ASIC function is modulated by interaction with other proteins, as discussed in 
(Wemmie, Price & Welsh, 2006) and updated in (Kellenberger & Schild, 2015). 
	  
ASIC	  pharmacology	  
It needs to be noted that currently ASIC inhibition is not used clinically. The presented 
compounds except for amiloride, which is clinically used as ENaC inhibitor, have been 
characterized in cell systems and in part also in animal models. An interesting recent review 
of ASIC pharmacology is provided by (Baron & Lingueglia, 2015). Based on the known 
physiological and pathological roles of ASICs, drugs inhibiting them could have many uses, 
such as analgesia, neuroprotection after ischemic stroke, and treatment of anxiety.  
Amiloride, the prototype ASIC small molecule blocker has a low potency (EC50 of 10-100 
µM) and selectivity on ASIC peak currents and does not inhibit the sustained ASIC currents. 
Amiloride binds into the pore of ENaC and ASICs (Adams, Snyder & Welsh, 1999; Alijevic 
& Kellenberger, 2012; Schild, Schneeberger, Gautschi & Firsov, 1997). The site of action of 
other small molecule inhibitors on ASICs is not known. Amiloride derivatives modified at the 
5-position of the pyrazine ring by hydrophobic groups increased the potency for ASIC3 
inhibition by up to 100-fold (Kuduk et al., 2009). Nafamostat mesylate, an anti-inflammatory 
agent and protease inhibitor, contains a guanidinium moiety as do amiloride and GMQ, and 
was shown to inhibit ASIC currents, including the sustained current of ASIC3, with IC50 
values of 2-70 µM (Ugawa, Ishida, Ueda, Inoue, Nagao & Shimada, 2007). The chemically 
unrelated compound A-317567 inhibits peak and sustained currents of neuronal and 
recombinant ASICs with IC50 values between 2 and 30 µM (Dube et al., 2005). Development 
of A-317567 derivatives yielded substances with higher affinity for ASICs, that lost however 
some of their selectivity (IC50 on ASIC3 of 400-500 nM, and for other neurotransmitter 
receptors of < 10 µM) (Kuduk et al., 2010). 
Inflammation increases ASIC mRNA expression, and it was shown that several non-steroidal 
anti-inflammatory drugs at doses close to those used in clinics prevent or suppress the RNA 
overexpression (Voilley, de Weille, Mamet & Lazdunski, 2001). These drugs inhibit also 
ASIC currents, however with potencies that are orders of magnitude lower than that on the 
cyclooxygenases (Voilley, de Weille, Mamet & Lazdunski, 2001). Several antiprotozoal 
diarylamidines inhibit ASICs with IC50 of 0.3-38 µM (Chen et al., 2010). A recent screening 
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of a fragment library followed by optimization led to ASIC3-inhibiting 2-aminopyridine 
derivatives with an IC50 of ~3 µM (Wolkenberg et al., 2011).  
Venom toxins acting on ASICs have been used to elucidate some of the physiological and 
pathological roles of ASICs (Wemmie, Taugher & Kreple, 2013). In addition, Complexes of 
ASIC with toxins were used to determine the crystal structure of ASICs in the presumable 
open conformation. The most important ASIC toxins are the gating modifiers PcTx1 of the 
spider Psalmopoeus cambridgei and the Mambalgins of the black mamba, the ASIC3 
inhibitor APETx2 of the sea anemone Anthopleura elegantissima and the activating Mit-toxin 
of the Texas coral snake that generates a sustained ASIC opening at pH 7.4 (rev. in (Baron, 
Diochot, Salinas, Deval, Noel & Lingueglia, 2013)). Mit-toxin and Mambalgins target several 
ASIC subtypes, while PcTx1 is selective for ASIC1a homomers and ASIC1a/2b heteromers, 
and APETx2 for ASIC3-containing channels. These toxins have so far not been shown to 
target other channels besides ASICs, with the exception of APETx2 that also inhibits some 
voltage-gated Na+ channel isoforms (Blanchard, Rash & Kellenberger, 2012; Peigneur, 
Beress, Moller, Mari, Forssmann & Tytgat, 2012). PcTx1 inhibits mammalian ASIC1a by an 
alkaline shift of the pH dependence of steady-state desensitization (leading to complete 
desensitization at pH 7.4), while Mambalgin inhibition is due to an acidic shift of the pH 
dependence of activation. The mechanisms of action of the other ASIC toxins are currently 
not known. Co-crystallization showed that PcTx1 binds to the acidic pocket of ASIC1, and 
that the much larger Mit-toxin binds to the wrist, palm and thumb domains, without however 
reaching into the acidic pocket (Baconguis, Bohlen, Goehring, Julius & Gouaux, 2014; 
Baconguis & Gouaux, 2012; Dawson et al., 2012). Site-directed mutagenesis indicated that 
Mambalgins also bind to the acidic pocket (Salinas et al., 2014; Schroeder et al., 2014).  
pH	  changes	  in	  the	  brain	  and	  role	  of	  ASICs	  in	  synaptic	  signaling	  in	  the	  CNS	  
Physiological	  extracellular	  pH	  changes	  during	  neuronal	  activity	  	  
The resting extracellular pH (pHe) value in the interstitial fluid of brain tissues can vary be-
tween 7.15 and 7.33 depending on the brain area and is generally about 0.1-0.2 pH units more 
acidic than the blood pH (Mutch & Hansen, 1984; Syková & Svoboda, 1990). Since 
membrane depolarization, ion transport and metabolic activity affect the pHe, changes in pHe 
are commonly observed during neuronal activity and in changed metabolic states, such as e.g. 
ischemia (Chesler, 2003; Dmitriev & Mangel, 2001; Kraig, Ferreira-Filho & Nicholson, 1983; 
Krishtal, Osipchuk, Shelest & Smirnoff, 1987; Siesjö, von Hanwehr, Nergelius, Nevander & 
Ingvar, 1985). Active brain neurons generate ATP by oxidative phosphorylation, which leads 
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to production of CO2, while astroglial cells are primarily glycolytic, producing lactate 
(Deitmer, 2002). Information about the variations of extracellular pH in the CNS of mammals 
comes mainly from studies with anesthetized rodents and in vitro preparations in which the 
pHe was recorded using optical techniques or pH-sensitive microelectrodes (Chesler, 2003). 
Upon repetitive electrical stimulation the neuronal activity of the mammalian CNS produces a 
general pattern of pHe changes containing three phases (Chesler, 1990; Chesler, 2003; 
Makani & Chesler, 2010).  An initial short (<200ms) transient alkaline shift of typically 0.01-
0.2 pH units, occurring within tens of ms after the beginning of the stimulus, is followed by a 
long-lasting, slowly developing acidosis that reaches a maximal acidic shift of 0.1-0.25 pH 
units 20-60s after the beginning of the repetitive stimulation. In the third phase, the pH returns 
to the initial value. Since these measurements represent in most cases tissue pH changes it is 
possible that locally, as e.g. in synapses, the pH changes may have different amplitudes and 
kinetics. The brain pH is buffered by the bicarbonate-carbon dioxide buffer. The buffering 
capacity of the interstitial fluid depends therefore on the bicarbonate and CO2 concentration 
and co-determines the magnitude of extracellular pH changes (Du et al., 2014; Highstein, 
Holstein, Mann & Rabbitt, 2014). The buffer capacity shows regional variations, and may be 
lower than originally thought (Chesler, 2003; Tong, Chen & Chesler, 2006).  
The transient alkalinization mentioned above has been reported in hippocampus in several 
studies (Chen & Chesler, 2015; Chen & Chesler, 1992; Gottfried & Chesler, 1996; Krishtal, 
Osipchuk, Shelest & Smirnoff, 1987). Inhibition of the plasma membrane Ca2+-ATPase 
(PMCA) prevented the transient alkaline shift in hippocampal neurons effectively, suggesting 
that the activity of this transporter, that exchanges internal Ca2+ for external H+, generates the 
alkaline shift (Kreitzer, Collis, Molina, Smith & Malchow, 2007; Makani & Chesler, 2010) 
(Makani et al., 2010). Depending on the brain region, the initial alkaline shift can be more or 
less pronounced or even inexistent (Venton, Michael & Wightman, 2003; Yamamoto, 
Borgula & Steinberg, 1992). The regional differences in the magnitude of the initial alkaline 
shift may be due to different expression or activity of PMCA, ion channels and other acid-
base transporters and to differences in buffering capacity. The alkalinization occurs in the 
same time frame as do excitatory post-synaptic currents and is therefore fast enough to 
modulate fast synaptic transmission (Gottfried & Chesler, 1996). Figure 4 illustrates the 
different mechanisms leading to pH changes in the synapse. The alkaline shift is also reduced 
by pharmacological blockade of different ion channels involved in neurotransmission, 
indicating that it is directly associated with neuronal activity (Smith & Chesler, 1999). This is 
not the case for the following acidification, which appears to be associated with another 
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process. Several observations suggest that the acidic change is mostly due to the activity of 
glial cells (Chesler, 2003; Jendelová & Syková, 1991). It was suggested that the Na+-HCO3--
cotransporter NBC contributes to the lowering of the extracellular pH by the glia. Activation 
of NBC leads to transport of Na+ and HCO3- into the glial cell and thereby to extracellular 
acidification (Deitmer, 2002) (Fig 4).  
Protons	  and	  ASICs,	  a	  neurotransmitter-­‐receptor	  pair	  in	  the	  CNS?	  
In this section we present the experimental evidence for a role of protons as a 
neurotransmitter. We discuss then how ASICs contribute to synaptic signaling and long-term 
potentiation (LTP), thereby affecting learning and fear sensation. Finally, we review different 
observations suggesting that ASICs can strongly influence glutamate receptor function.  
Indirect evidence for synaptic cleft acidification during electrical signaling has been provided 
by studies that measured the inhibition of presynaptic voltage-gated Ca2+ channel currents - 
that are inhibited by protons – and estimated the acidification in the synaptic cleft to 0.2-0.6 
pH units (DeVries, 2001; Palmer, Hull, Vigh & von Gersdorff, 2003; Vessey et al., 2005). 
Recent studies with fluorescent pH indicators showed that presynaptic stimulation led to 
acidification of the synaptic cleft in synapses formed by vestibular hair cells and the calyx 
nerve terminal of the turtle Trachemys scripta elegans (Highstein, Holstein, Mann & Rabbitt, 
2014) and in synapses of mouse lateral amygdala (Du et al., 2014). These pH patterns 
differed from the alkalinization-acidification observed in earlier studies. The differences 
might be due to the different brain regions that were investigated or due to the configuration 
of the measurements. Several mechanisms may contribute to the acidification of the synaptic 
cleft. The synaptic vesicles containing neurotransmitters that are continuously replenished 
with protons by the H+-ATPase pumps are an important source of protons in synapses 
(Beyenbach & Wieczorek, 2006; Vavassori & Mayer, 2014). There is evidence that the pH of 
cholinergic, glutamatergic and GABAergic synaptic vesicles can reach values as acidic as pH 
~5.5 (DeVries, 2001; Dietrich & Morad, 2010; Fuldner & Stadler, 1982; Michaelson & 
Angel, 1980; Miesenbock, De Angelis & Rothman, 1998; Palmer, Hull, Vigh & von 
Gersdorff, 2003). The synaptic vesicles fuse with the presynaptic neuronal plasma membrane 
during neurotransmission and release their acidic content together with the neurotransmitters 
into the synaptic cleft. The acidification of the synaptic cleft observed in the lateral amygdala 
had only a small amplitude (<0.1 pH unit), and a time constant of 0.5-1 s, thus much slower 
than the release of synaptic vesicles (Du et al., 2014). Highstein et al. also observed an 
acidification time course of ~0.5 s (Highstein, Holstein, Mann & Rabbitt, 2014). The slow 
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kinetics may point to acid-base transporters as the source of this proton release into the 
synaptic cleft. Consistent with this hypothesis, it was demonstrated in cultured rat cerebellar 
granule cells that transient synaptic cleft acidification during GABAergic transmission was at 
least in part due to the activity of the Na+/H+ exchanger (Dietrich & Morad, 2010).  
The activity of many neuronal ion channels is pH-dependent (Table 4), suggesting that the 
pHe changes during neuronal activity modulate ion channel function. In general, alkaline 
extracellular pH favors inward currents, thus enhancing excitability, while acidic extracellular 
pH depresses excitability in many circumstances (Chesler, 2003) and can be considered as 
negative feedback since it is caused by neuronal stimulation. The initial short alkalinization is 
sufficient for relieving the proton block of a significant fraction of NMDA receptors and to 
activate different classes of voltage-gated calcium channels, thus increasing the glutamatergic 
excitation and boosting neurotransmitter release (Makani et al., 2012; Tombaugh & Somjen, 
1996). ASICs are directly activated by extracellular protons, in contrast to most other 
excitatory ion channels, which are inhibited by acidification. Administration of specific 
ASIC1a antagonists or disruption of the ASIC1a gene eliminates the majority of the acid-
induced currents in the CNS neurons (Wemmie, Taugher & Kreple, 2013; Wu et al., 2013). 
This demonstrates that the ASIC1a homomers and ASIC1a-containing heteromers are the 
principal sensors of rapid extracellular acidification in the brain. ASIC1a, -2a and -2b are 
widely expressed in the CNS (rev. in (Kellenberger & Schild, 2015; Wemmie, Taugher & 
Kreple, 2013)). Localization by immunohistochemistry studies, evidence for the interaction 
with the postsynaptic proteins PICK1 and AKAP150, as well as co-localization with PSD-95 
in spines indicate together that ASIC1a has a somatodendritic distribution (Zha, 2013). The 
ASICs in the postsynaptic site are well situated to detect rapid synaptic pH changes.  
A recent study established expression of a light-activated proton pump in mouse astrocytes to 
induce local extracellular acidification with light with high temporal precision to activate 
ASICs present on nearby neurons (Li, Yang & Canessa, 2014). Using this approach, efficient 
action potential induction by repetitive acidification was demonstrated.  
In the lateral amygdala, presynaptic stimulation activated postsynaptic ASIC currents. 
Perfusion of glutamate receptor blockers inhibited 95% of the amplitude of the observed 
excitatory post-synaptic currents. The remaining 5% of the excitatory post-synaptic current 
amplitude were mediated by ASICs, since this current was absent in the presence of amiloride 
or if the ASIC1a gene was deleted (Du et al., 2014). A similar situation with a contribution of 
ASICs to 5% of the excitatory post-synaptic current amplitude was also found in nucleus 
accumbens (Kreple et al., 2014). High-frequency stimulation at 100 Hz produced LTP of 
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excitatory post-synaptic potentials (EPSPs) in the hippocampus of wild type but not ASIC1a(-
/-) mice (Wemmie et al., 2002). The ASIC1a(-/-) mice displayed mildly defective spatial 
learning and eyeblink conditioning, consistent with decreased LTP. There is currently a 
controversy regarding the involvement of ASIC1a in hippocampal LTP, since in a different 
model of ASIC1a knockout mice, in which ASIC1a was deleted at early embryonic stages – 
in contrast to the classical knockout used in the above study - normal LTP at CA3-CA1 
synapses was observed (Wu et al., 2013). The origin of this discrepancy is not understood, but 
might involve roles of ASIC in synapse development. Another recent study found that 
pharmacological blockade of ASIC1a in hippocampal synapses impaired LTP, confirming 
thereby the initial observation by Wemmie et al. (Quintana et al., 2015).  
The hippocampal CA1 area is particularly vulnerable to ischemia and undergoes delayed 
neuronal death in humans and several animal models after an ischemic attack (Kirino, 1982; 
Kuroiwa, Bonnekoh & Hossmann, 1990). The AMPA receptors show a high degree of post-
ischemic plasticity to contribute to the excitotoxicity in the CA1 region by two mechanisms, 
anoxic LTP during the first hours, and an increased expression of Ca2+-permeable AMPA 
receptor types (lacking the GluA2 subunit) several hours later (Hsu & Huang, 1997; 
Pellegrini-Giampietro, Zukin, Bennett, Cho & Pulsinelli, 1992). After an oxygen-glucose 
deprivation, anoxic LTP was observed in organotypic hippocampal slice cultures of wt mice, 
but was absent in slice cultures of ASIC1a(-/-) mice or after pharmacological blockade of 
ASIC1a (Quintana et al., 2015). The presence of active ASIC1a was also required for the 
increased expression of Ca2+-permeable AMPARs after oxygen-glucose deprivation. 
Inhibition of ASIC1a or of Ca2+-permeable AMPARs was sufficient to protect neurons of the 
CA1 area, illustrating the important role of ASICs in neurodegeneration in this context. 
 
ASIC1a(-/-) mice have reduced innate fear and show deficits in conditioned fear behavior 
(Wemmie, Taugher & Kreple, 2013). The fear-related behavior is in many cases correlated 
with CO2 and acid sensing and was rescued in ASIC1a(-/-)  mice by injection of a viral vector 
in the basolateral nuclei of the amygdala that restored ASIC1a expression locally (Coryell et 
al., 2009; Ziemann et al., 2009). Two recent studies showed that ASIC1a is critical for LTP at 
the synapses of the fear circuitry between the cortex and the basolateral nuclei of the 
amygdala (Chiang, Chien, Chen, Yanagawa & Lien, 2015; Du et al., 2014). The study by 
Chiang et al. investigated LTP at various synapses of amygdala neurons and found that the 
extent of LTP at different synapses correlated with the ASIC current density in postsynaptic 
neurons. Cell type-specific deletion of ASIC1a showed that ASIC-dependent LTP is required 
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at several amygdala synapses for fear learning. ASIC4 does not form functional channels but 
was shown to downregulate the expression of other ASIC subunits (Donier, Rugiero, Jacob & 
Wood, 2008). ASIC1a expression is therefore expected to be upregulated in ASIC4-/- mice, 
and it was indeed shown that ASIC4 knockout mice have an increased freezing response  
(Lin, Chien, Chiang, Liu, Lien & Chen, 2015).  A recent study with rats suggests a species 
difference with regard to the role of ASICs in the fear circuitry. This study showed that 
ASIC1a activation reduces anxiety in rats, by enhancing inhibition in the basolateral 
amygdala (Pidoplichko et al., 2014). The reasons for this opposite role of ASICs in fear 
behavior of mice and rats is currently not understood, and the rat data rely so far on one single 
study. Given the complexity of the expression and role of ASIC1a in the mouse fear circuitry 
(Chiang et al., 2015) it seems plausible that the ASIC expression pattern may be different 
between the fear circuitry of mice and rats. The role of ASICs in fear expressions of humans 
is currently not known.  
Several studies have shown that ASICs interact functionally with glutamate receptors in 
synaptic signaling, and that ASIC function is required for LTP, as discussed above (Du et al., 
2014; Kreple et al., 2014; Quintana et al., 2015; Wemmie et al., 2002). In the initial LTP 
study in hippocampus it was shown that activation of postsynaptic ASICs removes the Mg2+ 
block of NMDA receptors, since LTP was only disrupted in ASIC1a(-/-) mice in physiological 
extracellular Mg2+ concentrations, but was normal at low Mg2+ concentrations (Wemmie et 
al., 2002). This does however not explain the more recent observations in the amygdala, the 
nucleus accumbens and in hippocampal cultures after oxygen-glucose deprivation. In the 
amygdala, the absence of ASIC1a decreased the EPSC amplitude only slightly, impaired 
however the LTP strongly (Du et al., 2014). Similarly, the presence or absence of ASIC1a 
strongly influenced glutamate receptor function in the nucleus accumbens (Kreple et al., 
2014). The mechanism of this functional interaction of ASIC1a with glutamate receptors is 
not understood. There are however indications that the presence of ASICs can influence the 
density of dendritic spines and the glutamate receptor composition (Kreple et al., 2014; Zha, 
Wemmie, Green & Welsh, 2006). An earlier study had shown an interaction between NMDA 
receptors and ASICs in the context of ischemia by demonstrating that NMDA receptor 
activity leads to phosphorylation of ASIC1a by CaMKII that enhances ASIC currents and 
leads to ischemic cell death (Gao et al., 2005).  
In summary, pH changes occur in the CNS during neuronal and metabolic activity. The 
synaptic cleft is acidified upon presynaptic stimulation, leading to the activation of 
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postsynaptic ASICs. In spite of their small contribution to the postsynaptic currents, ASICs 
play a critical role in synaptic signaling.   
ASICs	  and	  other	  ion	  channels	  sense	  the	  extracellular	  pH	  in	  the	  PNS	  
Nociceptive fibers conduct signals from the periphery to the CNS that are induced by a 
variety of potential tissue-damaging stimuli such as heat, pressure and chemicals. Many 
different substances that can modulate this signaling are released during tissue damage and 
inflammation. Although protons are the smallest modulators, they have dramatic effects on 
diverse properties of sensory neurons. Many different types of acid sensors are expressed by 
primary sensory neurons and especially by nociceptors, illustrating the vital importance of 
acid-base sensing and regulation. Tissue acidification occurs for example during ischemia, 
inflammation, cancer pain, and in muscle during exercise. It has been proposed that rapid 
localized pH changes may occur in the environment of peripheral nerves (Martin & Jain, 
1994).  In this section we review first the roles of ASICs in pain sensation. We then describe 
the ASIC currents in PNS neurons and provide evidence for species differences. We discuss 
the apparent paradox, that ASICs sense slowly developing and long-lasting pH changes 
although their activity is mostly transient. Finally, we present observations showing that 
ASICs are not the only pH sensors in the PNS and that they cover together with other ion 
channels proton sensing over a wide pH range.  
Role	  of	  ASICs	  in	  pain	  sensation	  
A large body of experimental data underlines the importance of sensory neuron ASICs in 
acid-induced nociception (Deval & Lingueglia, 2015; Sluka & Gregory, 2015). Studies with 
human volunteers showed that the pain due to iontophoresis or injection of acid solutions in 
the skin was inhibited by amiloride and that it followed the pH dependence of ASIC1a and 
ASIC3 (Jones, Slater, Cadiou, McNaughton & McMahon, 2004; Ugawa, Ueda, Ishida, 
Nishigaki, Shibata & Shimada, 2002). Deletion of ASIC3 in mice reduced several forms of 
inflammation- and chronic acidification-related pain (Sluka, Winter & Wemmie, 2009). 
Intrathecal administration of ASIC3-specific siRNA to rats diminished pain behaviors 
induced by inflammation or wounding (Deval et al., 2011; Deval et al., 2008). The role of 
ASIC3 in pain sensation was further confirmed when it was shown that local injection of the 
ASIC3 activator GMQ induced pain behaviors that depended on the presence of ASIC3 (Yu 
et al., 2010). The use of toxins showed that ASIC1 channels of the PNS are also involved in 
pain sensation. Injection of the ASIC-activating Mit-toxin of the texas coral snake in the 
mouse paw induced pain that depended on the presence of ASIC1a (Bohlen et al., 2011). 
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Peripheral injection of Mambalgin, which inhibits several ASIC subtypes, exerted an 
analgesic action due to its inhibition of ASIC1b (Diochot et al., 2012). ASICs are also 
expressed in pain-processing areas of the CNS. Administration to the CNS of PcTx1 and of 
Mambalgin inhibited pain behaviors, indicating a role of central ASICs in pain sensation 
(Diochot et al., 2012; Mazzuca et al., 2007), in addition to the more obvious role of ASICs as 
pH sensors in the PNS. Two mouse models in which ASIC currents were suppressed – 
expression of a dominant negative ASIC3 mutant and a triple ASIC1a/ASIC2/ASIC3 
knockout – showed increased pain behavior, indicating that some aspects of the role of ASICs 
in pain sensation are not understood yet (Kang et al., 2012; Mogil et al., 2005).  
The neuropeptides Calcitonin gene-related peptide (CGRP) and substance P contribute to 
inflammation and are secreted from sensory nerve terminals in response to tissue 
acidification.  CGRP induces vasodilation and substance P promotes increased vascular 
permeability leading to plasma extravasation during neurogenic inflammation (Hoyer & 
Bartfai, 2012; Walker, Conner, Poyner & Hay, 2010). Since the neuropeptide secretion is 
Ca2+-dependent, TRPV1 and ASICs, which induce Ca2+ entry directly or via depolarization-
induced activation of Cavs, may mediate acidification-induced neuropeptide secretion. 
Experiments using specific pharmacological inhibitors or gene knockout identified TRPV1 
but not ASICs as the pH sensors for the acid-induced neuropeptide secretion from sensory 
neurons (Boillat, Alijevic & Kellenberger, 2014; Fischer, Reeh & Sauer, 2003; Pan, 
Gonzalez, Chang, Chacko, Wein & Malykhina, 2010; Weller, Reeh & Sauer, 2011). It is 
likely that the transient ASIC current is too short to induce neuropeptide release, and that a 
sustained current, as the one mediated by TRPV1 is required.  
Peng et al. showed recently that disruption of ASIC3 in mice reduced itch and pain in 
response to local co-injection of acid and a pruritogen (Peng et al., 2015). A similar effect was 
obtained when GMQ was injected alone, suggesting that persistent ASIC3 activity may be 
sufficient to induce itch. Interestingly it has previously been shown that ASIC3 is potentiated 
by another pruritogen, serotonin (Wang et al., 2013). Whether the pruritogenic effect of 
serotonin is mediated by ASIC3 has however not been explored yet.  
Expression	  pattern	  and	  cellular	  functions	  of	  ASICs	  in	  the	  PNS	  
Expression of the different ASIC subunits has been shown in primary afferent neurons 
innervating the skin, eye, ear, taste buds, heart, gut, skeletal muscle and joints (rev. in 
(Kellenberger & Schild, 2015; Wemmie, Taugher & Kreple, 2013)). ASIC function has been 
measured in small- and large-diameter neurons of the trigeminal, nodose and dorsal root 
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ganglia of mice and rats (Benson et al., 2002; Boillat, Alijevic & Kellenberger, 2014; Deval 
& Lingueglia, 2015; Poirot, Berta, Decosterd & Kellenberger, 2006). ASIC-like currents have 
also been measured from human DRG neurons (Baumann, Chaudhary & Martenson, 2004). 
Sensory neurons express homo- and heterotrimeric ASICs, producing current subtypes with 
different pH dependence. In rat DRG neurons, pH50 values ranging from 6.6 to <4.5 were 
measured (Poirot, Berta, Decosterd & Kellenberger, 2006). The presence of ASIC2 in 
heteromeric ASICs tends to decrease the pH sensitivity of the channel (Table 4). Rat DRG 
neurons express heteromeric ASICs of different compositions or homomeric ASIC1a or 
ASIC3. The proportion of these current subtypes varied between studies (Deval et al., 2008; 
Poirot, Berta, Decosterd & Kellenberger, 2006). Rat DRG neurons express a high proportion 
of ASIC1 and ASIC3, with less ASIC2a and -2b (Boillat, Alijevic & Kellenberger, 2014; 
Deval et al., 2008; Poirot, Berta, Decosterd & Kellenberger, 2006). This is similar to the 
ASIC expression in human (Delaunay et al., 2012) but different from mouse DRGs that show 
predominant expression of ASIC2a and -2b (Drew et al., 2004; Hughes, Brierley, Young & 
Blackshaw, 2007). 
Since ASIC currents are mostly transient due to rapid desensitization, they last only a few 
seconds, even if an acidic extracellular environment persists. In addition, at a pH slightly 
below the physiological 7.4, some ASIC subtypes desensitize without apparent opening and 
are not available for a subsequent activation in case of a further acidification. From these 
observed properties it is expected that ASICs are best adapted to sense rapid changes in pH, 
but will not report the persistence of a changed pH. If a pH change occurs slowly, as is the 
case in ischemia and inflammation, it may even desensitize ASICs rather than activating 
them. Two different mechanisms may allow the ASICs to sense pH in such conditions, 1) the 
sustained current of some ASICs, and 2) modulation of ASIC function by diverse endogenous 
mediators. Several studies detected a sustained fraction of ASIC currents in DRG neurons and 
in cells expressing ASIC3 (Deval et al., 2011; Poirot, Berta, Decosterd & Kellenberger, 2006; 
Yagi, Wenk, Naves & McCleskey, 2006). Native ASIC currents in DRG neurons are 
positively modulated by several inflammatory mediators. Serotonin, ATP, lactic acid, 
arachidonic acid and hypertonicity are able to enhance the proton-induced ASIC3 current, in 
several cases by changing its pH dependence (Baron & Lingueglia, 2015; Light, Hughen, 
Zhang, Rainier, Liu & Lee, 2008). Also, the synthetic molecule GMQ and related endogenous 
polyamines such as agmatine and arcaine have recently been shown to activate a sustained 
current in ASIC3 at physiological pHe (Li, Yu, Zhang, Cao & Xu, 2011; Yu et al., 2010).  
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Extracellular	  pH	  modulation	  of	  ion	  channels	  in	  nociceptors	  
In the following paragraph we present the different pH sensors in PNS neurons, organized 
according to their pH sensitivity. Detailed information is provided in Table 4. The varied 
expression pattern of ASICs and other pH-sensitive ion channels suggests that pH changes 
may affect neuronal excitability to different extents in the various subpopulations of 
nociceptors.  
Fluctuations of the resting pH (pH 7.4-7.3): members of the two-pore K+ (K2P) channel 
family are constitutively open at resting membrane potentials. Their activity codetermines the 
hyperpolarized resting membrane potential of primary afferent neurons (Kang & Kim, 2006; 
Lesage & Lazdunski, 2000). Most K2P channels are inhibited by extracellular protons with a 
pH50 of ~7.4. A slight lowering of the pH will therefore shift the resting membrane potential 
towards more positive values (Lesage & Barhanin, 2011)(Table 4). One specific K2P subtype, 
TREK2, is activated by extracellular protons (Sandoz, Douguet, Chatelain, Lazdunski & 
Lesage, 2009).  
 
Mild extracellular acidosis (acidification to pH 7.2-6.4) inhibits different classes of K+ 
channels. Studies with human and rat DRG neurons provided evidence for an acidification-
induced depolarization that is mediated by K2P channels in this pH range (Baumann, 
Chaudhary & Martenson, 2004; Cooper, Johnson & Rau, 2004). For several K2P channels it 
was shown that their loss of function increased the sensation of pain (rev. in (Mathie & Veale, 
2015)). Acidification activates several types of ASICs in DRG neurons (Baumann, Chaudhary 
& Martenson, 2004; Dirajlal, Pauers & Stucky, 2003; Poirot, Berta, Decosterd & 
Kellenberger, 2006). In this pH range the native ASIC currents are in many cases mediated by 
different ASIC heteromers containing ASIC1a and/or ASIC3 or by ASIC1a or ASIC3 
homomers.  
Mild extracellular acidosis inhibits efficiently glutamatergic (Traynelis & Cull-Candy, 1990; 
Traynelis & Cull-Candy, 1991) and GABAergic transmission (Valeyev, Hackman, Holohean, 
Wood, Katz & Davidoff, 1999; Zhai, Peoples & Li, 1998), neutralizing thus the excitatory 
and inhibitory tone on neurotransmission. Voltage-gated Ca2+ channels are inhibited by 
extracellular acidification by mechanisms involving pore block and a shift in voltage 
dependence (Hille, 1992). Extracellular acidosis reduces in addition voltage-gated Na+ 
channel currents (Daumas & Andersen, 1993; Tombaugh & Somjen, 1996).  
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Severe extracellular acidosis (acidification to pH < 6.4) activates the whole repertoire of 
ASIC subtypes, including heteromers with a strong ASIC2 contribution. ASIC3 and several 
ASIC heteromers develop a sustained current at severe acidosis below pH 4.5. Thus, severe 
acidosis provides persistent ASIC-mediated depolarizing inputs. Electrophysiology and Ca2+ 
imaging experiments with rat DRG neurons showed that pH 6 induces an ASIC current in 50-
70% of DRG neurons (Boillat, Alijevic & Kellenberger, 2014; Deval et al., 2008; Poirot, 
Berta, Decosterd & Kellenberger, 2006). 40-80 % of the putative nociceptors investigated in 
these studies showed TRPV1-like activity. TRPV1 is a polymodal ion channel activated by 
capsaicin and a number of other stimuli including noxious heat (>42°C) endogenous 
arachidonic acid derivatives, ethanol, camphor and protons (Caterina, Schumacher, 
Tominaga, Rosen, Levine & Julius, 1997; Mickle, Shepherd & Mohapatra, 2015). TRPV1-
mediated sustained currents due to acidification are largely confined to sensory neurons with 
unmyelinated fibers and have a pH50 of ~5.4. Therefore, TRPV1 activation by protons alone 
requires severely acidic conditions (pH≤6). TRPV1 is however also modulated by protons and 
has a substantially higher pH sensitivity for modulation (pH50 ~7–6).  Mild acidosis can 
therefore sensitize the TRPV1 to other stimuli such as capsaicin and temperature. As a 
consequence the temperature threshold of TRPV1 activation is lowered at acidic pH, leading 
to TRPV1 activation at normal body temperature (Tominaga et al., 1998). DRG neuron 
recordings of TRPV1 null mice showed a complete loss of capsaicin sensitivity and an 
impairment of thermal and pH sensitivity. Behavioral studies demonstrated an important role 
of TRPV1 in nociception associated with thermal/mechanical hypersensitivity, with models of 
inflammation and with different chronic pain conditions (Barton et al., 2006; Caterina et al., 
2000; Honore et al., 2005; Keeble, Russell, Curtis, Starr, Pinter & Brain, 2005). 
Approximately 20 % of measured DRG neurons presented pH-sensitive inward currents that 
were not mediated by ASICs or TRPV1, indicating that they were mediated by other ion 
channels, as e.g. by the inhibition of K2P channels that would appear like an inward current. 
Upon acidification to pH 6, ASICs mediated larger currents and charge movements than 
TRPV1, due to their different pH sensitivity (Blanchard & Kellenberger, 2011; Poirot, Berta, 
Decosterd & Kellenberger, 2006).  
 
P2X are trimeric cation channels that are activated by extracellular ATP. P2X2 and P2X3 are 
highly expressed in nociceptors (Chen, Akopian, Sivilotti, Colquhoun, Burnstock & Wood, 
1995; Lewis, Neidhart, Holy, North, Buell & Surprenant, 1995). Disrupting P2X3 in mice 
decreased nociceptive behavior (Cockayne et al., 2000; Souslova et al., 2000). P2X receptor 
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activity is modulated by pH changes in sensory neurons. Extracellular acidification increases 
the P2X2 currents and inhibits P2X3 currents at low, and increases them at high ATP 
concentrations (Gerevich et al., 2007; King, Wildman, Ziganshina, Pintor & Burnstock, 
1997). Simultaneous ATP release and extracellular lactic acidification occur in skeletal 
muscle under exercise. Interestingly, there is evidence for a physical interaction between P2X 
receptors and ASICs and it was shown that ATP-induced P2X2 activation potentiates the 
acid-induced ASIC3 current by twofold. It is therefore likely that ATP and acidosis can 
converge to increase nociceptor excitability (Birdsong et al., 2010).  
 
ENaC	  	  
Function	  and	  regulation	  of	  ENaC	  
ENaC is composed of three different subunits, namely α, β and γENaC, encoded by three 
different genes (SCNN1A, SCNN1B and SCNN1G, respectively; see for review 
(Kellenberger & Schild, 2015)). In the kidney, ENaC is present in the aldosterone-sensitive 
distal nephron (ASDN), that is composed of the distal convoluted tubule (DCT), connecting 
tubule (CNT), and collecting duct (CD) segments (Fig. 6) (Rossier, Staub & Hummler, 2013), 
to allow fine-tuning of whole body Na+ homeostasis. Expression of ENaC is regulated 
transcriptionally but equally by post-translational modifications, which thereby determine its 
synthesis, trafficking and activity at the cell membrane (Rossier, 2014). This regulation 
occurs on the ENaC subunits themselves (Loffing et al., 2001), and/or on ENaC-regulating 
proteins such as the e.g. the serum- and glucocorticoid-regulated kinase 1 (Lang & Shumilina, 
2013). Aldosterone modulates ENaC activity by transcription-dependent and -independent 
mechanisms (Thomas, McEneaney & Harvey, 2007). Due to space constraints in this review, 
we refer to the extensive literature on ENaC regulation (Kellenberger & Schild, 2015; 
Rossier, Baker & Studer, 2015; Verouti, Boscardin, Hummler & Frateschi, 2015).  
ENaC	  function	  in	  different	  tissues	  
Role	  of	  ENaC	  in	  classical	  and	  non-­‐classical	  tissues	  and	  organs	  
The syndrome Pseudohypoaldosteronism-type-1 (PHA-1) was first described by Cheek and 
Perry in 1958 (Cheek & Perry, 1958). Patients suffering from PHA-1 present the following 
symptoms: renal salt wasting, hypovolemia and hypotension, hyperkalemia, metabolic 
acidosis, high plasma levels of renin and aldosterone, and respiratory illness. PHA-1 is caused 
by either mutations in mineralocorticoid receptors (autosomal dominant PHA-1) or by loss-
of-function mutations in ENaC subunits (autosomal recessive PHA-1) (Furgeson & Linas, 
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2010). The genetic dissection of ENaC along the mouse nephron highly suggests that the 
early ASDN (DCT and/or CNT, Fig. 6) is crucial for Na+ and K+ balance. Whereas animals 
with ENaC deficiency in the CD survive well even under salt restriction or K+ loading 
(Rubera et al., 2003), ENaC deficiency in the CNT and CD (Christensen et al., 2010), or 
reduced ENaC expression solely in CNT (Poulsen et al., 2015) alone is sufficient to induce a 
mild salt-losing phenotype. However, only the deletion of ENaC subunit expression in mice 
along the whole nephron mimics the severe human adult PHA-1 (Perrier et al., 2015). An 
additional relevant role of ENaC in the cortical collecting duct (CCD) can currently not be 
excluded. Table 5 provides an overview of studies with ENaC mouse models. The 
constitutive αENaC knockout mice develop respiratory distress syndrome and die soon after 
birth thus revealing an important role of the αENaC subunit in lung liquid clearance at birth 
(Hummler et al., 1996). The γENaC subunit seems to transiently facilitate neonatal lung liquid 
clearance at birth, suggesting equally important roles of the other ENaC subunits (Barker et 
al., 1998). Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung 
disease in transgenic mice (Mall, Grubb, Harkema, O'Neal & Boucher, 2004), unveiling an 
important role of ENaC in the regulation of the airway surface liquid volume (Mall et al., 
2010). In colon, αENaC-deficiency causes Na+ loss and aldosterone resistance, that is 
normally compensated by the renin-angiotensin-aldosterone system in the kidney (Malsure et 
al., 2014), thus these mice are able to maintain their Na+ and K+ homeostasis.   
Apart from its classical role as a membrane constituent of many salt-reabsorbing epithelia 
that facilitates Na+ movement across the tight epithelial in the distal nephron, distal colon, the 
ducts of salivary and sweat glands, and the lung, the expression of ENaC subunits is also 
reported in tissues and/or organs that seem not to be implicated in whole body Na+ 
homeostasis, such as the skin, tongue, eye and blood vessels (rev. in (Kellenberger & Schild, 
2015; Rossier, Staub & Hummler, 2013)). The analysis of genetically engineered mouse 
models started to reveal the role of ENaC in these tissues/organs, unveiling non-classical 
roles, namely in differentiation, barrier function, lipid synthesis and secretion (skin), but also 
migration of keratinocytes (Charles et al., 2008), and salt perception (tongue; (Chandrashekar 
et al., 2010),  Table 5). In the human eye, all ENaC subunits (α, β, γ, and δ) are expressed 
within the cornea, ciliary body, iris, and retina. β and γENaC subunits present distinct 
localizations (Krueger et al., 2012). The βsubunit is present in basal regions of the limbal 
epithelium, while the γ-subunit is present	   throughout all layers of the corneal epithelium but 
not in the basal regions of the limbal epithelium. Measurements of electrical potential 
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difference confirmed functional ENaC-mediated Na+-transport, which is likely implicated in 
maintaining hydration of the ocular surface (Yu et al., 2012). ENaC is also expressed in 
endothelial and vascular smooth muscle cells where its increased surface expression can lead 
to membrane stiffening and reduced release of nitric oxide (Jeggle et al., 2013). The 
contribution to hypertension of ENaC expressed in these cells remains however still to be 
determined (Kusche-Vihrog, Tarjus, Fels & Jaisser, 2014).  
ENaC	  and	  hypertension	  
According to the World Health Organization, hypertension or increased blood pressure 
strongly correlates with risk of cardiovascular events, stroke and kidney disease and thus 
represents the leading cause of death worldwide (Santulli, 2013). It was predicted that the 
number of hypertensive patients will reach 1.56 billion in 2025 (Kearney, Whelton, Reynolds, 
Muntner, Whelton & He, 2005) and will thus affect one third of adults in most developing 
and developed communities. Clinical practice guidelines have been written to provide a 
straightforward approach to manage hypertension (Weber & Anlauf, 2014). 95% of adults 
with high blood pressure have primary or essential hypertension with unknown cause, but it is 
widely accepted that genetic and environmental factors affect blood pressure. According to 
the American Society of Hypertension and the International Society of Hypertension, the 
treatment aims to control blood pressure and to deal with all risk factors for cardiovascular 
diseases, like e.g, overweight or stress (Weber & Anlauf, 2014). Lifestyle interventions have 
been identified to reduce blood pressure as e.g., weight loss, salt reduction, exercise and 
reduced alcohol consumption (Levenson, Skerrett & Gaziano, 2002). Lowering the salt intake 
decreases blood pressure (Bray et al., 2004; Vollmer et al., 2001) and prevents hypertension 
(Whelton, 1997). In addition, increased K+ intake improved blood pressure (Obel, 1989), 
although the combination of lower Na+ and higher K+ intake did not further decrease blood 
pressure (Chalmers et al., 1986). These findings highly suggest that food consumption may be 
primordial in the prevention and/or the treatment of hypertension, and the “Dietary 
Approaches to Stop Hypertension” reports that a diet composed of fruits, vegetables and low-
fat dairy products rich in Ca2+, Mg2+ and K+ exerts antihypertensive effects (Zemel, 1997).  
The diuretic hydrochlorothiazide, an inhibitor of the Na+Cl--cotransporter NCC, is the oldest 
and most used antihypertensive drug. Hypertension treatment also includes angiotensin-
converting enzyme inhibitors such as Captopril or, to avoid hypokalemia, K+-sparing diuretics 
such as amiloride, an inhibitor of ENaC, which provides the final renal adjustment to Na+ 
balance in the distal kidney (see for review (Saha et al., 2005; Weber & Anlauf, 2014)). 
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Treatment with inhibitors of ENaC resulted in substantial improvement in blood pressure, 
highly suggesting that increase in Na+ transport by ENaC may be a common and requisite 
component of salt-dependent forms of hypertension (Pratt, 2005). Thus, the combination of 
two or more drugs that includes ENaC inhibitors was proposed (Pratt, 2005; Vidt & 
Borazanian, 2003). ENaC may play an even more central role in Na+ retention in the 
generation of hypertension than previously thought (Pratt, 2005). Thiazide diuretics are 
currently among the most prescribed anti-hypertension drugs. They are often combined with 
other anti-hypertensive drugs (Weber, 2014). Next generation diuretics may block 
synergistically NCC and ENaC, and possibly in addition the Cl-/HCO3--exchanger pendrin in 
patients with fluid overloads such as congestive heart failure, nephrotic syndrome, diuretic 
resistance or generalized edema. They may also block one or more pathways known to 
upregulate ENaC activity (rev. in (Rossier, 2014; Verouti, Boscardin, Hummler & Frateschi, 
2015)).  
ENaC	  and	  cystic	  fibrosis	  
Cystic fibrosis (CF) is one of the most common hereditary life-threatening diseases. It is 
characterized by mutations in the gene coding for the cystic fibrosis transmembrane 
conductance regulator (CFTR) (Brennan & Schrijver, 2016). The most frequent mutation, the 
in-frame phenylalanine 508 deletion (∆F508) is responsible for 70% of CF mutations 
worldwide, and exists since the Paleolithic period (Morral et al., 1994). The respiratory failure 
and finally the death of patients suffering from CF are due to airway obstruction, 
inflammation, and chronic bacterial infections. CFTR allows hydration and thus mucus 
clearance of the airway surface of the epithelia by secreting chloride to the lumen of the 
airway epithelia (Boucher, 2007). In the case of CFTR mutations, the mutated receptor cannot 
reach the plasma membrane due to a trafficking defect, and as a consequence the airway 
epithelium gets dehydrated because of the incapacity of CFTR to secrete chloride (Denning, 
Ostedgaard & Welsh, 1992; Kartner, Augustinas, Jensen, Naismith & Riordan, 1992). 
Although medical treatment strategies for CF have evolved rapidly over these last years, there 
is still today no cure. Among the new approaches, miRNAs allow the regulation of post-
transcriptional gene expression. miRNAs can act either by repressing or by up-regulating 
genes of interest (Ramachandran et al., 2012). miRNA approaches have been recently 
proposed as promising therapeutic treatment of CF that could up-regulate the expression and 
the number of CFTR proteins that reach the cell surface, as demonstrated in primary human 
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airway epithelia (Ramachandran, Noorbakhsh, Defea & Hollenberg, 2012; Sonneville et al., 
2015).  
The depth of surface liquid of airways is regulated by Cl- secretion through CFTR and by Na+ 
absorption through ENaC. Reduced CFTR expression at the cell surface leads to ENaC 
upregulation, resulting in an increase of Na+ reabsorption and, consequently, to a dehydration 
of the airway surface (Clunes & Boucher, 2007). Interestingly, it was shown that a mouse 
model overexpressing the β subunit of the epithelial Na+ channel (ENaC) in the lower airways 
shows typical features of CF, namely reduction of the periciliary liquid weight in bronchi and 
tracheae, depletion of the airway surface volume, abnormal mucus transport, and reduction of 
the clearance of bacteria, with a mortality of ∼50% (Mall, Grubb, Harkema, O'Neal & 
Boucher, 2004). For 30 years inhalation of amiloride has been known to inhibit Na+ 
reabsorption in CF patients. ENaC inhibition improves mucociliary clearance and thereby 
retards the lung infection (Kohler, App, Schmitz-Schumann, Wurtemberger & Matthys, 
1986). Amiloride therapy may reduce morbidity and mortality if it is given early in life before 
the onset of the lung disease (Zhou et al., 2008). As amiloride has a short duration of action 
on airway surfaces, second and third generation amiloride analogues, as benzamil and 
phenamil, were generated and tested to improve both the affinity to ENaC and decreasing the 
reversibility of the ENaC inhibition (Hirsh et al., 2006). Benzamil presents the highest 
potency and is rapidly absorbed from the mucosal surface to the cytosol. However, in vivo 
pharmacodynamic experiments in sheep have shown that amiloride and benzamil have the 
same efficiency (Hirsh et al., 2004). More recently, Parion compound N-(3,5-diamino-6-
chloropyrazine-2-carbonyl)-N-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanine 
methanesulfonate (552-02) was tested in cystic fibrosis bronchial epithelial cells and in sheep 
for mucociliary clearance after aerosol dosing. Compared to amiloride, 552-02 induced 
greater airway surface liquid expansion in bronchial epithelial cells. In addition, 552-02 
increased the mucociliary clearance in sheep at the time of administration and 4 to 6h later 
(Hirsh et al., 2008). In summary, the development of new ENaC blockers, as 552-02, with a 
higher potency, higher selectivity, and durability, is of clinical importance for the treatment of 
cystic fibrosis lung disease.       
Aldosterone-­‐dependent	  and	  -­‐independent	  regulation	  of	  ENaC	  
Aldosterone-­‐dependent	  ENaC	  regulation	  	  
Several hormones regulate ENaC activity (e.g., aldosterone, vasopressin, angiotensin, insulin, 
rev. by (Verouti, Boscardin, Hummler & Frateschi, 2015)). Among them, the 
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mineralocorticoid aldosterone acts on the principal cells in the ASDN (Fig. 6). Aldosterone is 
secreted by the adrenal gland in response to a small increase of K+ concentration in blood, or 
decrease of vascular volume, which activates the renin-angiotensin-aldosterone system, 
thereby maintaining the extracellular Na+ concentration and the blood pressure within 
physiological ranges (Bollag, 2014). Interestingly, independently of the renin-angiotensin-
aldosterone system, K+ itself mediates aldosterone secretion from the adrenal gland 
(Williams, 2005). The genomic response to aldosterone has been extensively analyzed and 
occurs 4-24 hours following an aldosterone stimulus. In this phase, aldosterone is translocated 
into the nucleus, where it binds to the mineralocorticoid receptor (MR), and stimulates further 
synthesis of “aldosterone-induced proteins” like ion transporting proteins, such as the α 
subunit of ENaC and the α1 subunit of the Na+-K+-ATPase (Pearce, Soundararajan, Trimpert, 
Kashlan, Deen & Kohan, 2015). The rapid effects of aldosterone on target tissues are far less 
well understood and are still controversial, since they are coupled to MR or to a yet 
unidentified membrane-associated aldosterone receptor (Dooley, Harvey & Thomas, 2012). 
These non-genomic effects occur within minutes to 2h after aldosterone stimulus (Bollag, 
2014). Thereby, the synthesis of ion transporter proteins is not required (Le Moellic et al., 
2004). Aldosterone may activate the ERK1/2 MAPK cascade independently of MR (Rossol-
Haseroth et al., 2004). Furthermore, activation of the PKC/protein kinase D signaling 
pathway through the c-Src-dependent trans-activation of the epidermal growth factor receptor 
may also contribute to early ENaC trafficking in response to aldosterone (Dooley, Harvey & 
Thomas, 2012). Thus, some of the early responses may potentiate the genomic effects of 
aldosterone through e.g., the phosphorylation of channels and/or transporters.  
 
Aldosterone-­‐independent	  ENaC	  regulation	  	  
ENaC activity is preserved in MR knockout mice (Berger et al., 1998), demonstrating that 
aldosterone is not the only modulator of ENaC. Furthermore, aldosterone synthase(-/-) mice 
survive even under low salt diet, demonstrating again an aldosterone-independent 
compensatory mechanism (Makhanova, Sequeira-Lopez, Gomez, Kim & Smithies, 2006). 
Interestingly, a study of Nesterov and colleagues clearly demonstrated by measuring ENaC 
activity in cut open tubules of aldosterone synthase(-/-) mice that aldosterone regulates ENaC 
only in the distal part of the nephron (CNT/CCD), whereas in the DCT2/CNT, ENaC 
regulation is aldosterone-independent (Nesterov, Dahlmann, Krueger, Bertog, Loffing & 
Korbmacher, 2012). Other hormones such as e.g. insulin, vasopressin, and angiotensin II 
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regulate ENaC activity as well (Verouti, Boscardin, Hummler & Frateschi, 2015). Indeed, in 
adrenalectomized mice, vasopressin is upregulated and ENaC function is not compromised 
(Mironova, Bugaj, Roos, Kohan & Stockand, 2012). Furthermore, more recently, angiotensin 
II has been proposed to upregulate γENaC in the DCT in AS (-/-) mice treated with high K+ 
diet (2% K+), thereby regulating Na+ and K+ homeostasis (Todkar et al., 2015) by increasing 
the electrochemical driving force for K+ excretion through renal K+ channels (van der Lubbe 
et al., 2013). This phenomenon is aldosterone-independent and involves a decrease of the 
upstream NCC activity (Sorensen et al., 2013; van der Lubbe et al., 2013). Several recent in 
vivo studies confirm that upon hyperkalemia, the distal Na+ delivery is increased, by 
decreasing the NCC activity, while upon hypovolemia, both NCC and ENaC are upregulated 
to improve Na+ absorption (Rengarajan, Lee, Oh, Delpire, Youn & McDonough, 2014; van 
der Lubbe, Zietse & Hoorn, 2013; Vitzthum, Seniuk, Schulte, Muller, Hetz & Ehmke, 2014). 
Thus, angiotensin II acts on the switch from K+ secretion upon hyperkalemia to Na+ 
reabsorption under hypovolemia, that is mediated via several kinases	   (Arroyo, Ronzaud, 
Lagnaz, Staub & Gamba, 2011; Mamenko et al., 2013). This so-called “aldosterone paradox” 
phenomenon (Arroyo & Gamba, 2012), determines NCC and ENaC as key players for Na+ 
and K+ balance within the DCT. As expected for an aldosterone-dependent ENaC regulation, 
treating WT mice with high Na+ and high K+ diet leads to an increase of the plasma 
aldosterone and an increase of the βENaC subunit and serum- and glucocorticoid-regulated 
kinase 1 protein expression (Vitzthum, Seniuk, Schulte, Muller, Hetz & Ehmke, 2014). 
However, even in presence of the MR antagonist spironolactone or the ENaC blocker 
amiloride, blood pressure stays increased (Vitzthum, Seniuk, Schulte, Muller, Hetz & Ehmke, 
2014). This highly suggests the existence of other, currently unknown regulatory mechanisms 
in a Na+-repleted state. Several other aspects of ENaC regulation are still unresolved, as e.g. 
the molecular mechanisms underlying the aldosterone-dependent and independent regulation 
of ENaC, the differential distribution of ENaC channels along the nephron or the possibility 
of a cross-talk between NCC and ENaC within the DCT2.  
Is	  ENaC	  regulated	  by	  potassium	  diet?	  
Up to now, evidence for ENaC regulation through K+ is poor. In case of hyperkalemia, 
angiotensin II is known to improve the delivery of Na+ to the distal part of the nephron to 
increase ENaC-mediated electrochemical secretion of K+ through renal K+ channels. As 
discussed above, this phenomenon is aldosterone-independent and leads to a decrease of the 
upstream NCC activity. To date, more is known about the regulation of NCC activity upon K+ 
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loading than on ENaC regulation in this context. Low K+ diet is a strong stimulus to increase 
NCC activity (Sorensen et al., 2013; van der Lubbe et al., 2013) by an aldosterone-
independent mechanism (Castaneda-Bueno et al., 2014; Vallon et al., 2009). Acute oral K+ 
loading resulted in a rapid NCC dephosphorylation and inactivation of NCC (Sorensen et al., 
2013). In contrast, high Na+ diet mediates a decrease of NCC phosphorylation by oxidative-
stress-responsive kinase 1/Ste20-related proline alanine rich kinase in an aldosterone-
dependent manner, increasing thereby NCC activity (Chiga et al., 2008). ENaC activity 
within the DCT2/CNT segments is however independent of aldosterone (Nesterov, 
Dahlmann, Krueger, Bertog, Loffing & Korbmacher, 2012; Todkar et al., 2015) and the 
mechanism of ENaC regulation in the DCT2/CNT in this context is currently unknown. 
Furthermore, a regulation of ENaC through solely low K+ diet has not been investigated so 
far. The recent study by Perrier and colleagues (Perrier et al., 2015) clearly demonstrates that 
in nephron-specific αENaC knockout mice, hyperkalemia becomes the determining factor in 
regulating NCC activity, regardless of Na+ loss, and thus remains the predominant and life-
threatening feature to be avoided.  
	  
Regulation	  of	  ENaC	  by	  proteases	  	  
In addition to the hormonal regulation through e.g. vasopressin (Ecelbarger, Kim, Wade & 
Knepper, 2001) and insulin (Marunaka, Hagiwara & Tohda, 1992), ENaC is regulated by 
changes in both extracellular and intracellular sodium. An increase in extracellular Na+ 
reduces ENaC activity (Fuchs, Larsen & Lindemann, 1977), and this Na+ self-inhibition can 
be abolished by treatment with extracellular proteases (Chraibi & Horisberger, 2002). The 
first evidence of ENaC regulation by proteases was reported in 1983 when Garty and 
Edelman applied high doses of trypsin (1 mg/ml) to toad urinary bladder and recorded a 
decrease in the amiloride-sensitive Na+ current probably as a result of proteolytic digestion of 
the ENaC channel (Garty & Edelman, 1983). When lower doses of trypsin or chymotrypsin 
(1-5 µg/ml) were applied, ENaC activity expressed in the Xenopus oocytes was strongly 
stimulated by an increase in channel open probability (Chraibi, Vallet, Firsov, Hess & 
Horisberger, 1998). Since then, trypsin and chymotrypsin are commonly used as experimental 
tools to achieve maximal ENaC activation. In 1997, Vallet and colleagues screened a Xenopus 
A6 cell complementary DNA library to detect proteins involved in the control of ENaC 
activity, and isolated the first membrane-bound serine protease whose co-expression with 
ENaC induced a 3-fold increase in the ENaC Na+ current amplitude (Vallet, Chraibi, 
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Gaeggeler, Horisberger & Rossier, 1997). Consequently, this serine protease was termed 
channel-activating protease-1 (CAP1). It is encoded by the Prss8 gene and is orthologous to 
human prostasin containing a glycosylphosphatidyl-inositol (GPI) domain as a plasma 
membrane anchor (Vallet, Chraibi, Gaeggeler, Horisberger & Rossier, 1997). The mouse 
counterpart was cloned two years later from a CCD cell line derived from mouse kidney 
(Vuagniaux et al., 2000). Measurements of this cell line revealed that the ENaC-mediated Na+ 
current was less sensitive (only ~50% of control) to the serine protease inhibitor aprotinin 
(Vuagniaux et al., 2000). This suggested that ENaC activation depends on more than one 
protease, and led to the discovery of two additional membrane-bound serine proteases that 
increased ENaC currents 6 to 10-fold. Accordingly, these type II-oriented membrane-bound 
serine proteases were called CAP2 (also known as Tmprss4) and CAP3 (also known as 
matriptase) (Vuagniaux et al., 2000). Interestingly, CAP3 has been shown to decrease an acid-
activated ASIC current as measured by two-electrode voltage clamp in Xenopus oocytes 
(Clark, Jovov, Rooj, Fuller & Benos, 2010). Since then, several other proteases were added to 
the list of ENaC regulatory molecules, all increasing ENaC currents. TMPRSS3 which is 
mutated in deafness (Guipponi et al., 2002), furin (Hughey et al., 2004), neutrophil elastase 
(Caldwell, Boucher & Stutts, 2005), kallikrein (Patel, Chao & Palmer, 2012; Picard et al., 
2008), plasmin (Buhl et al., 2014; Svenningsen et al., 2009), metalloprotease meprin β subunit 
(Garcia-Caballero et al., 2011), cathepsin-S (Haerteis et al., 2012), urokinase plasminogen 
activator (Chen et al., 2014; Ji, Zhao, Komissarov, Chang, Liu & Matthay, 2015), alkaline 
phosphatase from Pseudomonas aeruginosa (Butterworth, Zhang, Heidrich, Myerburg & 
Thibodeau, 2012; Butterworth, Zhang, Liu, Shanks & Thibodeau, 2014), and trypsin IV 
(Haerteis et al., 2014), are all proteases able to activate ENaC in in vitro settings. So far, only 
CAP1, kallikrein and the urokinase plasminogen activator have been confirmed as 
physiological regulators of ENaC activity by in vivo studies using genetically modified or 
spontaneous mutant mice (Chen et al., 2014; Frateschi et al., 2012; Malsure et al., 2014; 
Picard et al., 2008; Planes et al., 2009), and it was shown that the serine protease CAP2 is not 
implicated in ENaC regulation in vivo in kidney and colon (Keppner et al., 2015). The 
mechanism by which these proteases activate the channel is still largely debated. Several 
researchers claim and provided evidence for a direct activation mediated by proteolytic 
cleavage of ENaC that would lead to the removal of inhibitory domains and/or changes in the 
three-dimensional structure of the channel resulting in its activation (Shi, Carattino, Hughey 
& Kleyman, 2013). Indeed, this hypothesis is quite tempting, as most of these enzymes are 
membrane-bound proteins facing the extracellular side of the plasma membrane or soluble 
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molecules and thus potentially located in close proximity with ENaC. Although cleavage 
products of the different ENaC subunits have been observed under various conditions, 
functional evidence is still missing. In this regard, CAP1 is peculiar and its action on ENaC 
still controversial. A CAP1 cleavage site (RKRK) was identified in the γ subunit of ENaC 
downstream the proposed consensus cleavage site for furin. On the one hand, the mutation of 
either the CAP1 cleavage site or the furin cleavage site abolished the activation of ENaC by 
CAP1 in Xenopus oocytes, and prevented the appearance of a smaller fragment of the γ 
subunit (Bruns et al., 2007; Carattino, Hughey & Kleyman, 2008). However, mutation of the 
CAP1 catalytic triad that should render the protease catalytically-inactive, did not prevent full 
ENaC activation and moreover induced γ subunit cleavage as well as its wild-type counterpart 
(Andreasen, Vuagniaux, Fowler-Jaeger, Hummler & Rossier, 2006; Bruns et al., 2007; 
Carattino et al., 2014). Other studies indicated that there is no consistent correlation between γ 
subunit cleavage and ENaC activation (Fejes-Toth, Frindt, Naray-Fejes-Toth & Palmer, 2008; 
Harris, Garcia-Caballero, Stutts, Firsov & Rossier, 2008). In addition, although CAP1 is 
indeed a positive regulator of ENaC in vivo, since CAP1 loss-of-function or absence 
significantly decreases ENaC basal activity (Frateschi et al., 2012; Malsure et al., 2014; 
Planes et al., 2009), the cleaved fragment originating from γENaC was still observed in the 
colon or in the lung of tissue-specific CAP1 knockouts (Malsure et al., 2014; Planes et al., 
2009). Interestingly, both the wild-type and the catalytically inactive mutant CAP1 are able to 
elicit skin pathology when overexpressed in mouse models of ichthyotic skin disorders 
(Crisante et al., 2014; Frateschi et al., 2011). This indicates that as for ENaC activation, the 
catalytic triad of CAP1 is dispensable for provoking pathophysiological effects. The presence 
of cleaved fragments originating from ENaC subunits may nevertheless have physiological 
meanings, even if they most likely do not origin from direct cleavage by CAP1. Very 
recently, Zachar et al. reported that, in the human kidney, γENaC is subject to proteolytic 
processing, yielding fragments compatible with furin cleavage, and that proteinuria is 
accompanied with cleavage at the putative CAP1 site of γENaC (Zachar et al., 2015). Table 6 
highlights the proteases involved in the regulation of ENaC with particular emphasis on their 
physiological implication.  
Protease inhibitors achieve another level of regulation of ENaC activity. Using a proteomic 
approach, Garcia-Caballero et al. identified SPLUNC1 (the short palate, lung, and nasal 
epithelial clone 1) as an ENaC inhibitor highly expressed in the airways, colon and kidney 
(Garcia-Caballero et al., 2009), with the inhibitory domain located at the N terminus (Hobbs 
et al., 2013). α1-antitrypsin, an anti-serine protease found in human plasma and lung 
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epithelial fluid (Lazrak et al., 2009), inhibits amiloride-sensitive Na+ transport in Xenopus 
oocytes and alveolar fluid clearance in mice (Lazrak et al., 2009). A role of SerpinB1, a 
highly efficient inhibitor of neutrophil serine proteases, was described in the cystic fibrosis 
airways suggesting a possible link to ENaC regulation (Cooley, Sontag, Accurso & Remold-
O'Donnell, 2011). Although a putative impact of the pulmonary protease inhibitors secretory 
leukocyte protease inhibitor I and trappin-2 on ENaC and Na+ transport in the airways 
remains unknown, their antibacterial and anti-fungal properties towards common micro-
organisms in cystic fibrosis patients have been reported (Sallenave, 2010; Zani et al., 2011). 
Similarly, loss of either of the two Kunitz-type transmembrane serine protease inhibitors, 
hepatocyte growth factor activator inhibitor (HAI)-1 or -2, expressed by tubular epithelium in 
kidney (Yamauchi, Kataoka, Itoh, Seguchi, Hasui & Osada, 2004), is associated with 
embryonic lethality in mice (Mitchell et al., 2001; Tanaka et al., 2005). All developmental 
defects in HAI-1- and HAI-2-deficient embryos are rescued by simultaneous CAP1 
deficiency, but not by absence of ENaC, suggesting that ENaC activity is not involved (Szabo 
et al., 2012). The protease activity of CAP1 can be inhibited by the serine protease inhibitor 
protease nexin-1 (also known as SerpinE2) (Chen, Zhang & Chai, 2004; Crisante et al., 2014). 
Nexin-1 is known to be an endogenous inhibitor for α-thrombin, plasmin, and plasminogen 
activators, and Wakida et al. showed an inhibitory effect of nexin-1 on CAP1-induced ENaC 
currents and proposed that nexin-1 could exert a natriuretic role by inhibiting CAP1 activity 
(Wakida et al., 2006).  We also recently reported an inhibitory effect of nexin-1 on both wild-
type and catalytically inactive mutant CAP1 in vitro and in an in vivo model, indicating that 
the catalytic site of CAP1 is dispensable for nexin-1 inhibition (Crisante et al., 2014), and 
demonstrating a novel inhibitory interaction between CAP1 and nexin-1. This opens the 
search for specific CAP1 antagonists that are independent of its catalytic activity.  
Altogether, proteases (in particular serine proteases) and their inhibitors are important 
regulators of ENaC function. Although progress has been made on the mechanism of such 
regulations, the precise signaling pathways remain to be disclosed, which necessitates the 
usage of in vivo models to define their physiological significance. 
 
Outlook	  
As discussed above, all ENaC/DEG family members share the same subunit topology and 
form Na+ channels that are inhibited by amiloride (Kellenberger & Schild, 2015). More 
recently it was found that ENaC and ASICs are both regulated by proteases, and that also 
ENaC is pH-dependent (Table 4). The tissue expression and physiological roles are however 
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very different between ASICs and ENaC. Whereas ENaC is well known for its role in 
mediating Na+ entry in epithelial cells, especially in the kidney, lung and colon, ASICs are 
predominantly found in the CNS and the PNS. The question arises whether in tissues 
expressing both ASIC and ENaC channels, overlapping functions can be identified. No 
function has so far been found for ENaC in the ear and in DRG neurons, in contrast to ASICs 
(Raouf et al., 2012; Rusch & Hummler, 1999). There is currently evidence for roles of both 
ENaC and ASICs in mechanosensation in arterial baroreceptors (Drummond, Welsh & 
Abboud, 2001; Lu et al., 2009). ENaC β and γ subunits are also expressed in vascular smooth 
muscle cells where they contribute to pressure-induced constriction. Similarly, ASICs in 
vascular smooth muscle cells likely regulate vascular tone and chemotactic migration 
(Drummond, Jernigan & Grifoni, 2008). Other overlapping functions of ENaC and ASICs 
may still be discovered. Interestingly, two recent studies indicate that overexpression of 
ASICs together with ENaC may lead to the formation of hybrid ENaC/ASIC channels 
(Jeggle, Smith, Stewart, Haerteis, Korbmacher & Edwardson, 2015; Kapoor et al., 2011).  
What will be the next challenges and progresses in ENaC and ASIC research? For ASICs, it 
will be important to identify and develop specific and potent small molecule inhibitors, and 
this with two aims, first to confirm the physiological and pathological roles of ASICs, and 
second to take advantage of ASIC pharmacology to treat human diseases. The available 
structural information will together with complementary approaches lead to a better 
understanding of the molecular mechanisms of ASIC function, allowing a rational drug 
development. For the ENaC field, ENaC distribution and function have still to be unveiled in 
classical and non-classical tissues and organs and may reveal so far unknown functions of 
ENaC as e.g. a defect in lipid synthesis and processing in skin (Charles et al., 2008). 
Conditional and inducible gene targeting of single ENaC subunits in adult mice may help to 
shed some light on these important issues.  
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Figure	  legends	  
Figure 1. Relation and roles of ENaC and ASICs.  
(A) Phylogenetic tree of the ENaC/degenerin family, showing besides ASIC and ENaC the 
subfamilies pickpocket (PPK), degenerin (DEG), the FMRFa-activated channel FaNaC and 
the bile acid-sensing ion channel BASIC (also known as hINaC or BLINaC). (B) Illustration 
of the different physiological and pathological roles of ASICs and ENaC. 
 
Figure 2. ASIC and ENaC subunit organization.  
(A) Schematic view of one subunit in the context of the trimeric ASIC, highlighting the 
different domains finger (purple), knuckle (turquoise), β-ball (orange), palm (yellow), thumb 
(blue) and transmembrane domains (red). (B) Structure of an ASIC1 subunit, based on the 
crystal structure obtained from chicken ASIC1 binding MitTx (Baconguis, Bohlen, Goehring, 
Julius & Gouaux, 2014). The domains are colored as in (A). (C) Model of the extracellular 
part of αENaC (Kashlan & Kleyman, 2011). Coloring as in (A); the transmembrane part was 
not modeled. 
 
Figure 3. Functional properties of ASIC. 
(A) Action potential induction by extracellular acidification to pH 6.4, mediated by ASICs, 
measured by whole-cell current-clamp from a mouse hippocampal neuron. (B) pH5-induced 
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current recorded in whole-cell voltage-clamp to -60 mV from a Chinese hamster ovary cell 
stably transfected with ASIC1a. (C) pH dependence of steady state desensitization (open 
circles) and of activation (black squares) of ASIC1a. In steady-state desensitization 
experiments, cells were exposed for 55 s to the indicated conditioning pH, and a stimulation 
pH 6 solution was applied for 5 s to open the not yet desensitized channels. The normalized 
current response at pH 6 is plotted as a function of the conditioning pH. For ASIC1a 
activation, the cells were perfused by a pH 7.4 solution and once per minute this solution was 
changed to one of acidic pH to open the channels. The normalized current is plotted as a 
function of the stimulation pH. 
 
Figure 4. Extracellular pH changes during neurotransmission in CNS.  
Illustration based on experiments performed in hippocampal, photoreceptor, amygdala and 
calyx synapses, showing a synapse between a pre- and postsynaptic neuronal terminal and an 
astrocyte. The numbers 1-3 (colored in blue) represent potential mechanisms for the initial 
alkaline shift recorded in hippocampal synapses: neurotransmission stimulates calcium 
signaling in the perisynaptic cells. As a consequence the mechanisms of calcium buffering 
system are stimulated. One of these mechanisms involves the PMCA, which pumps the 
accumulated intracellular calcium ions out of the cell in exchange for external protons, 
leading to extracellular alkalinization. The numbers 4-6 (colored in red) represent potential 
mechanisms underlying the acidic shift. The glial Na+-HCO3--cotransporter (NBC) causes a 
gradual extracellular acidification (4). Intense neurotransmission increases astrocytic energy 
demand, resulting in lactate and CO2 production (5). For clarity only the lactate into 
presynaptic terminals is shown. Lactate is transported outside the astrocyte by the H+-coupled 
monocarboxylate transporter (MCT) and CO2 can freely diffuse, also leading to extracellular 
acidification at the synaptic cleft. Fast acidifications at the synaptic cleft may also occur as a 
result of synaptic vesicle release and also by non-vesicular release involving an undefined 
transporter (6). For simplification, only the transport of protons and of HCO3- is shown in the 
figure (grey arrows; protons are red dots). The black arrows indicate the activation of synaptic 
vesicle release by calcium entry.  
 
 
Figure 5. Extracellular pH sensitive ion channels in the PNS. 
Illustration based on experiments performed in small-diameter DRG neurons innervating 
peripheral organs. The scheme indicates the pathway of a signal from the sensory nerve 
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terminals in an organ (in the example the heart) to the spinal cord and the brain and focuses 
on two specific locations, the peripheral nerve terminal (left) and the signaling along the 
sensory nerve axon (right).  Only the ion channels that are modulated by pHe on the nerve 
terminal and along the axon are shown, indicated by the symbols “+”	   (stimulation by 
lowering of pHe) and “-”	   (inhibition by lowering of pHe). Red symbols indicate that this 
modulation increases excitability, and blue symbols indicate that it decreases excitability. The 
number of symbols correlates with the pH dependence of the regulation (Table 4) as indicated 
at the bottom of the figure.  
 
 
Figure 6. ENaC expression along the aldosterone-sensitive distal nephron 
Schematic view of a nephron, with detailed views of the ion transport mechanisms in cells of 
the DCT, CNT and CCD. CLCN/Kb, voltage-sensitive chloride channel Kb; ROMK, renal 
outer medullary potassium channel. 
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Tables	  
Table 1.  Links to online information in the IUPHAR/BPS Guide to 
PHARMACOLOGY 
Targets 
Acid-sensing (proton-gated) ion channels (ASICs) 118 
Cystic fibrosis transmembrane conductance regulator 129 
Ionotropic glutamate receptors 75 
Epithelial sodium channels (ENaC) 122 
Na-Cl symporter 970 
P2X receptors 77 
Prostasin 2400 
Renin 2413 
Sodium-dependent HCO3- transporter 171 
Transient Receptor Potential channels 78 
Two-P potassium channels 79 
Voltage-gated Na+ channels 82 WNK	  lysine	  deficient	  protein	  kinase 643 
 
Ligands 
amiloride 2421 
A-317567 4116 
APETx2 4135 
agmatine 4127 
aldosterone 2872 
arcaine 4137 
benzamil 4145 
Calcitonin gene-related peptide 681 
GMQ 4203 
nafamostat 4262 
P552-02 4280 
phenamil 4281 
Psalmotoxin 1 4292 
triamterene 4329 
vasopressin 2168 
(The numbers on the right column represent the target or ligand identification number in the 
database. They will be necessary for making the hyperlinks, should however not appear in the 
final table.) 
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Table 2 Biophysical properties of ASICs 
 pH50 activation pHD50 Steady-
state 
desensitization 
Desensitization 
time constant 
(s) 
Most important 
sites of 
expression 
ASIC1a 6.2-6.6 ~7.2 ~0.4 CNS, PNS 
ASIC1b 5.9-6.3 ~6.7 ~0.9 PNS 
ASIC2a 4.0-4.9 ~5.6 ~1.4 CNS, PNS 
ASIC3 6.4-6.7 ~7.1 ~0.3 PNS 
The desensitization time constant is indicated for stimulation pH close to the pH50. These data 
are from different articles and reviews (Alijevic & Kellenberger, 2012; Blanchard & 
Kellenberger, 2011; Hesselager, Timmermann & Ahring, 2004; Poirot, Vukicevic, Boesch & 
Kellenberger, 2004; Wemmie, Taugher & Kreple, 2013). ASIC4, not indicated in the table, 
has not been shown so far to form functional channels and is mainly expressed in the CNS 
(Lin, Chien, Chiang, Liu, Lien & Chen, 2015). 
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Table 3 ASIC modulators  
Modulator class Important 
examples 
Effect Site of 
action 
References  
Divalent cations Ca2+, Mg2+, 
Ba2+ 
Acidic shift of pH 
dependence 
Not known (Babini, Paukert, Geisler 
& Grunder, 2002; Immke 
& McCleskey, 2003) 
  Pore block Acidic 
residues in 
pore entry of 
ASIC1a 
(Paukert, Babini, Pusch & 
Grunder, 2004) 
Neuropeptides Dynorphin, 
FMRFa 
Acidic shift of pH 
dependence of 
steady-state 
desensitization, 
slowing of 
desensitization and 
induction of 
sustained current 
Not known (Askwith, Cheng, Ikuma, 
Benson, Price & Welsh, 
2000; Vick & Askwith, 
2015) 
Proteases Tissue 
kallikrein, 
trypsin 
Acidic shift of pH 
dependence 
Cleavage in 
finger 
domain 
(Poirot, Vukicevic, 
Boesch & Kellenberger, 
2004; Su, Tang, Liu, 
Zhou & Dong, 2011; 
Vukicevic, Weder, 
Boillat, Boesch & 
Kellenberger, 2006) 
Protein kinases PKA, PKC Changes expression 
and function 
Intracellular Rev. in (Kellenberger & 
Schild, 2015; Wemmie, 
Taugher & Kreple, 2013) 
Other Arachidonic 
acid 
Increase of peak 
current amplitude 
Not known (Allen & Attwell, 2002; 
Smith, Cadiou & 
McNaughton, 2007) 
 Nitric oxide Increase of peak 
current amplitude 
Extracellular (Cadiou et al., 2007) 
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Table 4: extracellular pH-sensitive ion channels expressed in CNS and PNS neurons 
Inhibition 
by pHe 
(pH50Inh.) 
Ion channels Mechanisms / Comments 
pH 8.6 
(PNS) (1) TASK2 
Decrease of K+ pore occupancy and open 
probability 
pH 7.4 - pH 
7.3 (CNS, 
PNS) 
(2) TREK1, (3) Kv1.4, (4) TASK1, (5) TRAAK, 
(6) KCNQ2/3 
(2) C-type inactivation enhanced, (4) open 
probability reduced, (6) I max reduced, 
depolarizing shift of the activation 
pH 7.3 - pH 
7 (CNS, 
PNS) 
(7) NMDAR, (8) GABAAR, (9) voltage-gated 
calcium channels (Cav), (10) glycine receptors 
(7) Reduced burst duration, decreased opening 
frequency, (8), (10) subunit- and agonist-
dependent, (9) I max reduced, depolarizing shift of 
the activation 
Mixed pH 
effects 
(CNS, PNS) 
(11) TWIK1 From pH 7.5 to pH 6.5: current enhanced. Below pH 6.5: current inhibited. 
pH 6.7 - pH 
6.5 (CNS, 
PNS) 
(12) Kir2.3, (13) TASK3, (14) TRPM2, (12), (13) conductance and open probability reduced  
pH 6.3 – pH 
6.2 (CNS, 
PNS) 
(15) AMPAR,  (16) Ca2+-sensing non-selective 
cation channels, (17) Kv1.5 
(15) enhancing desensitization, (17) facilitation of 
a non-conducting state 
pH 6 - pH 
4.6 (CNS, 
PNS) 
(18) Kainate receptors, (19) Kv1.3, (20) IA, IK, 
(21) INa, (22) Nav1.2 
(18) Subunit dependent, (20) depolarizing shift of 
the inactivation, (19), (21) I max reduced, (21), 
(22) depolarizing shift of the activation 
Stimulation 
by pHe 
(pH50Act.) 
Ion channels Mechanisms / Comments 
pH 7.3 
(CNS, PNS) (23) TREK2, (24) P2X2 (24) Sensitization to activation by ATP  
pH 6.5 - 
pH6 (CNS, 
PNS) 
(25) ASIC1a, (26) ASIC1a/2b, (27) ASIC3, (28) 
δβγ-ENaC  
pH 5.8 - pH 
3 (CNS, 
PNS) 
(29) ASIC1a/2a, (30) ASIC2a, (31) ASIC2a/2b  
Mixed pH 
effects 
(CNS, PNS) 
(32) BK and  (33) Kv1.3 associated with ASICs  ~50% inhibition of BK and Kv1.3 currents at pH 7.4 
Mixed pH 
effects 
(CNS, PNS) 
(34) P2X3 
The ATP concentration dependence of the current 
is shifted to higher concentrations and its maximal 
current amplitude is increased   
(37), (38) ~ 
pH 5.4 for 
proton 
activation 
(37) pH 7 – 
pH 6 for 
(35) TRPV1, (36) TRPV4 
(35), (36) Direct activation by strong acidosis (< 
pH 6). (35) Sensitization to other stimuli such as 
capsaicin and temperature by mild acidosis (pH 7-
6) 
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proton 
sensitization 
(CNS, PNS) 
pH 6.5-pH 
4 (CNS, 
PNS) 
(37) nAChRs α3/β4 (38) HCN, Ih 
(37) Increased of the agonist-induced current and 
changed kinetics. Agonist- and subunit- dependent. 
(38) Activation of Ih current 
The ion channels are classified based on their pH sensitivity. Table citations: (1), (2), (4), 
(5), (13), (23): (Ehling, Cerina, Budde, Meuth & Bittner, 2015; Lesage & Barhanin, 2011) 
(3): (Claydon et al., 2000). (4), (13): (Plant, 2012). (6): (Prole, Lima & Marrion, 2003). (7), 
(15), (18): (Traynelis & Cull-Candy, 1990; Traynelis & Cull-Candy, 1991). (8) (Wilkins, 
Hosie & Smart, 2005; Zhai, Peoples & Li, 1998). (9), (20), (21) (Tombaugh & Somjen, 
1996). (10) (Chen, Dillon & Huang, 2004). (11) (12) (Zhu, Chanchevalap, Cui & Jiang, 
1999). (14) (Starkus, Fleig & Penner, 2010). (15) (Lei, Orser, Thatcher, Reynolds & 
MacDonald, 2001). (16) (Chu et al., 2003). (17) (Kehl, Eduljee, Kwan, Zhang & Fedida, 
2002). (18) (Mott, Washburn, Zhang & Dingledine, 2003). (19) (Petroff et al., 2008; Somodi 
et al., 2004). (21) (Daumas & Andersen, 1993). (22) (Vilin, Peters & Ruben, 2012). (24) 
(King, Wildman, Ziganshina, Pintor & Burnstock, 1997). (25), (30) (Alijevic & Kellenberger, 
2012) (26) (Sherwood, Lee, Gormley & Askwith, 2011). (27) (Waldmann, Bassilana, 
Deweille, Champigny, Heurteaux & Lazdunski, 1997). (28) (Ji & Benos, 2004; Yamamura, 
Ugawa, Ueda, Nagao & Shimada, 2004). (29) (Bartoi, Augustinowski, Polleichtner, Grunder 
& Ulbrich, 2014). (31) (Ugawa et al., 2003). (32), (33) (Petroff et al., 2008). (34) (Gerevich et 
al., 2007) (Tominaga et al., 1998). (36), (Suzuki, Mizuno, Kodaira & Imai, 2003). (37) 
(Abdrakhmanova, Cleemann, Lindstrom & Morad, 2004; Abdrakhmanova, Dorfman, Xiao & 
Morad, 2002). (38) (Cichy et al., 2015). (41) (Birdsong et al., 2010). Table abbreviations: 
BK, big calcium-activated K+ channel; HCN, hyperpolarization-activated cyclic nucleotide-
gated channel; IA, A-type current of rapid inactivating K+ channels; Ih, current produced by 
HCN channels; IK, delayed rectifier K+ current; Imax, maximal current amplitude; INa, Na+ 
current; Kir, inward rectifier K+ channel; Kv, voltage-gated K+ channel; nAChR, nicotinic 
acetylcholine receptor; Nav, voltage-gated Na+ channel; P2X, Purinergic receptor; 
pH50Inh./Act., pH of half-maximal inhibition/activation; TASK, two-pore domain K+ channel; 
TRAAK, TWIK-related arachidonic acid-stimulated K+ channel; TREK, TWIK-related K+ 
channel; TRPM, transient receptor potential cation channel, subfamily M; TRPV, transient 
receptor potential cation channel subfamily V; TWIK, tandem of P-domain in a weak 
inwardly rectifying K+ channel. 
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Table 5. ENaC animal models  
Mouse model tissue / 
organ 
Phenotype  Reference 
αENaC KO 
(constitutive) 
 
 
 
 
 
 
 
 
 
 
 
 
 
kidney 
and lung 
neonatal death, lung fluid clearance failure, hyperkalemia and sodium loss (Hummler et al., 1996) 
 
 
increased number of  angiotensin II subtype 1 receptors in renal tissues and  
lowered blood pressure during the angiotensin II receptor blockade 
(Wang et al., 2001) 
skin 
 
decreased transcription of the alpha1-subunit of Na+,K+-ATPase (Blot-Chabaud et al., 
2001) 
 increased transepidermal water loss, higher skin surface pH, disturbed stratum 
corneum lipid composition and lamellar body secretion 
(Charles et al., 2008) 
 impaired directionality of galvanotaxis in keratinocytes (Yang, Charles, Hummler, 
Baines & Isseroff, 2013) 
 altered epidermal differentiation (Mauro et al., 2002) 
embryo inability to rescue the lethal embryonic phenotype in double αENaC and HAI-
1 (hepatocyte growth factor activator inhibitor-1) KOs 
(Szabo et al., 2012) 
ear normal mechano-electrical transducer apparatus (Rusch & Hummler, 1999) 
βENaC KO 
(constitutive) 
kidney hyperkalemia, neonatal death and type 1 pseudohypoaldosteronism (McDonald et al., 1999) 
γENaC KO 
(constitutive) 
kidney hyperkalemia, neonatal death and type 1 pseudohypoaldosteronism (Barker et al., 1998) 
CNT-specific 
αENaC KO 
(Hoxb7, 
constitutive)   
kidney normal sodium and potassium balance (Rubera et al., 2003) 
 normal ascites development (Mordasini et al., 2015) 
 abolished benzamil-sensitive component of Cl- absorption (Pech et al., 2012) 
 protection from lithium-induced nephrogenic diabetes insipidus  (Christensen et al., 2011) 
 presence of electroneutral, amiloride-resistant, thiazide-sensitive, 
transepithelial NaCl absorption in CNT 
(Leviel et al., 2010) 
 rosiglitazone-induced fluid retention (Vallon et al., 2009) 
 normal urinary acidification following furosemide alone and in combination 
with hydrochlorothiazide treatment 
(Kovacikova et al., 2006) 
CNT-specific 
αENaC KO 
(AQP2, 
constitutive)  
kidney higher urinary sodium excretion and hyperkalemia under Na+-deficient diet (Christensen et al., 2010) 
 attenuation of body weight and water increase following RGZ (rosiglitazone) 
treatment   
(Fu et al., 2015) 
nephron-
specific 
αENaC KO 
(inducible) 
 hyperkalemia and body weight loss under regular salt diet (Perrier et al., 2015) 
CNT-specific 
αENaC KO 
(constitutive) 
 type 1 pseudohypoaldosteronism symptoms during high dietary K+ loading (Poulsen et al., 2015) 
β and γENaC  
KOs  
(constitutive) 
sensory 
neurons 
normal mechanosensory behavior (Raouf et al., 2012) 
airway-
specific 
overexpressio
n βENaC-
transgene 
(constitutive)  
lung increased airway Na+ absorption, airway mucus obstruction and chronic 
airway inflammation 
(Zhou et al., 2011) 
unaltered development of airway cartilage (Bonora, Riffault, Marie, 
Mall, Clement & Tabary, 
2011)  
therapeutic effects of α1-antitrypsin on Pseudomonas aeruginosa infection (Nichols, Jiang, Happoldt, 
Berman & Chu, 2015) 
defective regulation of  airway surface liquid volume and ENaC-mediated Na+ 
absorption  
(Mall et al., 2010) 
αENaC KO 
(constitutive)  
tongue complete loss of salt attraction and sodium taste response (Chandrashekar et al., 
2010) 
βENaC - kidney  high blood pressure, metabolic alkalosis, hypokalemia with cardiac and renal (Pradervand et al., 1999b) 
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Liddle knock-
in 
(constitutive) 
hypertrophy under high salt intake 
 constitutive hyperactivity of ENaC in cortical connecting ducts (Pradervand et al., 2003) 
 maintained mineralocorticoid regulation of ENaC (Dahlmann, Pradervand, 
Hummler, Rossier, Frindt 
& Palmer, 2003) 
increased vasopressin-stimulated CFTR Cl- currents in CCD cells (Chang et al., 2005) 
lung no effect of hypoxia on amiloride-sensitive alveolar fluid clearance  (Gille et al., 2014) 
 increased alveolar fluid clearance and reduced severity of hydrostatic 
pulmonary edema 
(Randrianarison et al., 
2007) 
 pendrin gene ablation in Liddle homozygous does not eliminate nitric oxide-
sensitive net Cl- flux and  transepithelial potential difference 
(Pech et al., 2013) 
 intact regulation of airway surface liquid volume an  ENaC-mediated Na+ 
absorption   
(Mall et al., 2010) 
intestine increased aldosterone responsiveness of ENaC in colon (Bertog et al., 2008) 
heart decreased  action  potential  duration, intracellular Ca2+ transient  amplitude  
and  contraction   
(Perrier et al., 2005) 
βENaC 
hypomorphic 
mice 
(constitutive) 
kidney weight loss, hyperkalemia and decreased blood pressure on low-salt diets  (Pradervand et al., 1999a) 
lung impaired lung fluid clearance  (Randrianarison et al., 
2008) 
αENaC(-/-)Tg 
(αENaC 
CMV) 
(constitutive) 
lung, 
kidney 
and 
intestine 
rescued perinatal lethal pulmonary phenotype and partially restored Na+ 
transport in renal, colonic, and pulmonary epithelia 
(Hummler et al., 1997) 
lung reduced Na+ transport rate probably insufficient for airway fluid clearance and 
favoring pulmonary edema 
(Olivier, Scherrer, 
Horisberger, Rossier & 
Hummler, 2002) 
 predisposition to pulmonary edema and delayed resolution (Egli et al., 2004) 
heart absence of cardiac remodeling and fibrosis under a normal-salt diet (Wang et al., 2004) 
 increased  action  potential  duration, intracellular Ca2+ transient  amplitude  
and  contraction 
(Perrier et al., 2005) 
colon-specific 
αENaC KO 
(constitutive) 
intestine sodium loss and aldosterone resistance (Malsure et al., 2014) 
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Table 6 Proteases modulating ENaC in vitro and in vivo activity 
protease type ENaC regulation in vitro ENaC cleavage ENaC regulation in vivo 
CAP1/Prss8, 
also known as 
prostasin 
Membrane-
bound serine 
protease, GPI-
anchored 
Catalytically-independent 
and increased ENaC 
activity in X. oocytes and 
mCCD cells (Vallet, 
Chraibi, Gaeggeler, 
Horisberger & Rossier, 
1997; Vuagniaux et al., 
2000) (Andreasen, 
Vuagniaux, Fowler-Jaeger, 
Hummler & Rossier, 
2006). 
Cleavage of γENaC in 
transfected MDCK cells 
through catalytically active 
and inactive CAP1 (Bruns et 
al., 2007). Probable 
involvement of a second 
protease (Carattino et al., 
2014). 
40% decrease in ENaC-mediated Na+ 
currents in alveolar epithelial cells; 
unaltered ENaC cleavage in lung-specific 
CAP1 KO mice (Planes et al., 2009). 
Reduced ∆PDamil but normal ENaC 
processing in intestine-specific CAP1 KO 
(Malsure et al., 2014). 
CAP2/Tmprss
4 
Membrane-
bound serine 
protease, type 
II 
Catalytically-dependent 
and increased ENaC 
current in X. oocytes 
(Vuagniaux et al., 2000). 
Cleavage of all three ENaC 
subunits in X. oocytes 
(Garcia-Caballero, Dang, He 
& Stutts, 2008). Cleavage 
only in γENaC (Passero, 
Mueller, Myerburg, 
Carattino, Hughey & 
Kleyman, 2012).  
Normal ∆PDamil and ENaC processing 
in constitutive CAP2 KO (Keppner et al., 
2015). 
CAP3/matript
ase 
Membrane-
bound serine 
protease, type 
II 
Catalytically-dependent 
and increased ENaC 
current in X. oocytes 
(Vuagniaux et al., 2000). 
Mediates cleavage of ENaC 
at basic residues near the γ-
ENaC furin site (Kota, 
Garcia-Caballero, Dang, 
Gentzsch, Stutts & 
Dokholyan, 2012). 
Not determined. 
TMPRSS3 Membrane-
bound serine 
protease, type 
II 
Increased ENaC current in 
X. oocytes. TMPRSS3 
mutants fail to activate 
ENaC (Guipponi et al., 
2002). 
Not determined. Not determined. 
Furin Intracellular 
(subtilisin-like 
proprotein 
convertase 
family) 
Activated ENaC through 
suppression Na+ self-
inhibition (Sheng, 
Carattino, Bruns, Hughey 
& Kleyman, 2006). 
Cleaved α and γENaC in X. 
oocytes (Hughey et al., 
2004; Hughey et al., 2003). 
Not determined. 
neutrophil 
elastase 
soluble serine 
protease 
increased ENaC activity in 
cultured human bronchial 
epithelia. Increased open 
probability of near-silent 
channels in NIH-3T3 cells 
(Caldwell, Boucher & 
Stutts, 2005).  
neutrophil elastase-
dependent activation of 
γENaC (Caldwell, Boucher 
& Stutts, 2005; Harris, 
Firsov, Vuagniaux, Stutts & 
Rossier, 2007). 
not determined. 
kallikrein soluble serine 
proteinase 
activated ENaC in X. 
oocytes (Patel, Chao & 
Palmer, 2012).  
ENaC activation and 
cleavage abolished in mouse 
ENaC mutants (Patel, Chao 
& Palmer, 2012). 
blunted urinary Na+ excretion after 
amiloride injection and decreased colonic 
∆PDamil (Picard et al., 2008), and 
absence of the cleaved (70-kDa) γENaC 
in kallikrein KO mice (Picard et al., 
2008). 
plasmin soluble serine 
proteinase 
activated ENaC in M-1 
cells and X. oocytes 
(Svenningsen et al., 2009). 
released γENaC peptide 
(Passero, Mueller, Rondon-
Berrios, Tofovic, Hughey & 
Kleyman, 2008; 
Svenningsen et al., 2009). 
not determined. 
metalloprotea
se meprin β 
subunit 
cell surface or 
secreted 
meprin 
metalloprotein
ase 
increased ENaC in X. 
oocytes and epithelial cells 
(Garcia-Caballero et al., 
2011).  
cleavage of α and γ-ENaC 
subunits (Garcia-Caballero 
et al., 2011). 
not determined. 
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cathepsin-S lysosomal 
cysteine 
protease 
activated ENaC in X. 
oocytes and M-1 cells 
(Haerteis et al., 2012). 
γENaC cleavage (Haerteis et 
al., 2012). 
not determined. 
urokinase 
plasminogen 
activator 
membrane-
bound serine 
protease, GPI-
anchored 
catalytically-dependent 
activation of ENaC in X. 
oocytes (Ji, Zhao, 
Komissarov, Chang, Liu & 
Matthay, 2015). 
γ but not αENaC cleavage in 
X. oocytes (Ji, Zhao, 
Komissarov, Chang, Liu & 
Matthay, 2015). 
decreased ENaC activity in primary 
tracheal epithelial cells from urokinase 
plasminogen activator KO (Chen et al., 
2014). 
alkaline 
phosphatase 
from 
Pseudomonas 
aeruginosa 
phosphomono
esterase 
(periplasmic 
space in 
Gram-negative 
bacteria)  
activated ENaC in 
immortalized and primary 
human bronchial epithelial 
cells from both cystic 
fibrosis and non- cystic 
fibrosis patients 
(Butterworth, Zhang, 
Heidrich, Myerburg & 
Thibodeau, 2012; 
Butterworth, Zhang, Liu, 
Shanks & Thibodeau, 
2014). 
cleaved γENaC 
(Butterworth, Zhang, 
Heidrich, Myerburg & 
Thibodeau, 2012). 
not determined. 
trypsin IV and 
I 
 Increased ENaC activity 
by trypsin IV in human 
airway epithelial cells 
(Haerteis et al., 2014). 
ENaC cleavage and 
activation by trypsin IV (but 
not by trypsin I) (Haerteis et 
al., 2014). 
not determined. 
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